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ABSTRACT 
Metallic dental implants are an important treatment for the replacement of missing teeth. 
However, for esthetic and environmental issues, there is a need to develop non-metallic 
dental implant materials. In this thesis, two novel glass-ceramics (GCs), miserite and 
wollastonite, were synthesized for one-piece dental implant applications. Glasses were 
synthesized by wet chemical methods, followed by calcination, melting and quenching. 
The crystallization kinetics of these glasses were determined by differential thermal 
analysis (DTA). GC specimens were produced by cold pressing of the glass powder and 
sintering using schedules determined by DTA. The crystalline phases and microstructure 
of the GC samples were characterized by X-ray diffraction (XRD) and scanning electron 
microscopy (SEM), respectively. Miserite GC displayed an interlocking lath-like 
crystalline morphology. Mechanical testing results showed Dynamic Young’s modulus 
(E), 96±3 GPa, true hardness (Ho), 5.27±0.26 GPa, fracture toughness (KIC), 4.77±0.27 
MPa·m0.5, and brittleness index (BI), 1.11±0.05 µm-0.5, indicating suitable mechanical 
properties and machinability. Miserite GC showed excellent bioactivity, with formation 
of a hydroxyapatite surface layer when soaked in simulated body fluid (SBF). Osteoblast-
like cells exhibited attachment, spreading and proliferation on miserite GC surfaces, 
demonstrating biocompatibility. However, preliminary studies revealed that the chemical 
stability of miserite GC was not optimal, prompting us to modify the GC composition. 
Accordingly, wollastonite GC was synthesized; it consisted of dense acicular interlocking 
crystals and demonstrated excellent machinability. E, Ho and KIC were 90±3 GPa, 
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5.15±0.47 GPa and 4.91±0.26 MPa·m0.5, respectively. Importantly, chemical durability 
of wollastonite GC satisfied ISO 6872 specification for dental ceramics. Furthermore, 
when evaluated according to ISO 10993-14, there was little chemical degradation. In 
addition, the chemical stability tests had no significant effect on KIC (p>0.05). Bioactivity 
tests revealed that wollastonite GC induced the formation of bone-like carbonated 
hydroxyapatite when soaked in SBF. Moreover, wollastonite GC supported osteoblast 
attachment and proliferation. Osteoblast spreading, focal adhesion formation and alkaline 
phosphatase activity on this GC were comparable to those on a control zirconium-oxide-
based ceramic, indicating excellent biocompatibility. In conclusion, wollastonite GC is a 
promising material for non-metallic dental implant applications based on five tested 
qualities: mechanical properties, chemical stability, machinability, excellent bioactivity 
and biocompatibility.  
KEYWORDS 
Dental implant, Glass-ceramic, Miserite, Wollastonite, Dynamic Young’s modulus, 
Fracture toughness, True hardness, Machinability, Brittleness index, Chemical durability, 
Bioactivity, Cell attachment, Cell proliferation, Focal adhesion, Alkaline phosphatase 
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 CHAPTER 1  
INTRODUCTION 
Overview: This Chapter provides background information on dental implants, including 
an historical overview, a review of materials used for dental implants, and a description 
of the most relevant mechanical parameters of dental implants. The chapter also includes 
background information on glass-ceramics, including their properties and clinical 
applications, pertinent aspects of bone physiology, osseointegration of dental implants, 
and the bioactivity of biomaterials. It concludes with the study hypotheses and objectives 
of the study and an outline of the organization of the thesis. 
1.1 DENTAL IMPLANTS 
Dental Implant is defined as a “prosthetic device of alloplastic material(s) implanted into 
the oral tissues beneath the mucosal and/or periosteal layer, and/or within the bone to 
provide retention and support for a fixed or removable prosthesis”.1 Part of most dental 
implants is projected into the oral cavity and therefore subjected to wide range of physical 
and biological environments, in contrast to medical implants that are placed totally inside 
the body e.g. artificial hip, knee and silicone breast.2 
Theoretically, implants within bone would perform the same way as the natural tooth 
(Figure 1-1) through balancing between osteoblast and osteoclast activities, hence 
maintaining the health of the maxilla or mandible with minimal bone resorption.3 Dental 
implants must be capable of transferring occlusal forces to the adjacent bone through 
osseointegration as the bone anchors to the implant surfaces.4 In general, developing an 
optimal dental implant requires the collaboration among biomaterial, chemical, 
mechanical, physical, and biological interdisciplinary expertise.5 
 
2 
 
 
 
 
 
Figure 1-1: Comparison of natural tooth and implant with crown. Adapted with 
permission from Dental Implants,2nd edition.6 (Appendix A) 
 1.1.1 Historical Overview 
The replacement of missing teeth using dental implant restorations have been traced to 
ancient civilizations where seashells, wood, bone, ivory, gold and stone were used.1 
Throughout centuries, there were documentations of successful tooth transplantation for 
restoring missing teeth; human or animal teeth were used to replace missing teeth. In the 
early 19th century, cast gold tooth-root shaped implants were fixed into fresh extracted 
sockets and other materials were proposed such as platinum-lead implants, iridium and 
silver posts. However, complications were accompanied with different implant materials, 
designs and procedures leading to the beginning of “modern era” of dental restorations in 
1950s. Vitallium, an inert cast alloy, composed of cobalt, chromium and molybdenum 
was proposed as a dental implant material. This alloy was used for different applications; 
such as sub periosteal implants and orthopedic plates, screws, nails and joints.7 
The most important milestone in dental implants was the understanding of 
osseointegration phenomena by Brånemark8 in 1952. After 3 years, Brånemark and his 
team used the first titanium dental implant on a human subject8. In 1978, he reported the 
3 
 
breakthrough in Osseointegration Clinical Dentistry in a Toronto Conference with clinical 
insertion of 2768 implants soon after that.8 
The global dental implant market was valued at approximately $6.8 billion in 2011 and is 
predicted to increase by an average of 9.3% per year from 2011 to 2016.9 Over one 
million dental implants are inserted each year. These numbers continue to increase 
progressively, with almost $550 million of implant products sold to North American 
dentists in 2005.6 Success rates for mandibular implants (96-98%) and for maxillary 
implants (94-96%) were reported; these appeared to depend on bone quality, surgical 
techniques and primary implant retention and stability.7 
 1.1.2 Implant Biomaterials 
Metal alloys and ceramics are the two classes of biomaterials currently used for dental 
implants. 
1.1.2.1 Metallic Implants 
The current alloys used for dental implants belonged to two principal metallic systems: 
titanium-based alloys and cobalt-based alloys1,8,10 
Titanium-based alloys are considered as “materials of choice” due to their high strength-
to-weight ratio, desired physical and chemical properties, high corrosion resistance, 
outstanding biocompatibility, excellent fatigue feature and relatively low cost.7,11 It can 
be presented either in a 99.75% pure form known as commercial pure titanium (CPTi) or 
as an alloy with 6% aluminum and 4% vanadium (Ti-6Al-4V). CPTi has been used since 
1950 in medical applications due to its superior mechanical strength, corrosion resistance, 
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its welding ability and ease for shaping. CPTi alloys (monophasic-α) are available in four 
grades with disparate amounts of impurities of carbon, hydrogen, iron, nitrogen and 
oxygen. In spite of relatively small percentages of the interstitial impurities, they affect 
the mechanical properties of CPTi significantly. The limitations of CPTi lead to the 
development of biphasic α/β alloys (Ti-6Al-4V), which are currently the most commonly 
used alloys for medical applications.10 
Titanium is considered biocompatible due to its low dissolution rate and non-reactivity of 
the titanium-dissolution products leading to bone thriving and osseointegration.12,13 
Topography of the titanium surface can be modified, mechanically or chemically, to 
improve the rate and quality of osseointegration and to maximize bone-implant 
interaction such as sand blasting, plasma-spraying and chemical treatment of the implant 
surface.1,7,10,13 However, some titanium’s modifications (e.g. screw threading or 
deposition of coating) will reduce its fatigue strength. Many studies believed that 
bioactive coatings on dental implants might disrupt the inter-facial attachment with 
bone.10,14-16 
Under physiological conditions, titanium-based implants are in a passive state because of 
the thin layer of titanium oxide, of nm thickness, that is formed immediately over implant 
surfaces. This layer will be in contact with the tissues of the body. The superior corrosion 
resistance, biocompatibility, and osseointegration of titanium were ascribed to the 
presence of this layer.17 Different oxides such as TiO, TiO2, and Ti2O3 can be formed. 
Yet, TiO2 is considered to be the most stable oxide and usually is found after exposure to 
physiological environments. The crystalline structures of the oxide layer are changed 
according to implant surfaces.1,7 
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Even though titanium is considered as a material of choice for dental implants, its 
limitation has been investigated in several studies. Despite the long-term clinical success 
rate (10-16 years) of titanium dental implants, biological and technical complications did 
occur (48.03% up to 16 years).18,19 Sicilia et al19 found that diverse titanium allergic 
reactions were detected in some dental implant patient. Other studies and clinical reports 
addressed the relationship of titanium dental implant failures to allergic and 
hypersensitivity reactions, in spite of the deficiency of epidemiological studies.18-23 
Additionally, the cosmetic outcome of anterior dental implants might be unacceptable to 
the patients due to a greyish dark color line along the gingival tissues as a result of 
gingival resection or thin peri-implant gingival tissues.24 
1.1.2.2 Ceramics 
Ceramics exhibited outstanding biocompatibility, owing to their chemical stability. The 
color of ceramics can match the color of bone, enamel and dentin. Ceramic implant 
materials are classified into two categories: “inert” and “bioactive”.1 
Bioactive ceramics react directly with bone tissue; the result of this reaction is a direct 
chemical bond between the implant surfaces accompanied with new bone formation.25 
Bioactive ceramics are relatively brittle and partially soluble, making it not suitable for 
use in high-stress situations. Therefore, it is mainly used as bone filler or as surface 
coating. There is a great emphasis on bioactive and bioresorbable ceramics to elicit 
normal tissue regeneration and form an intimate bond with bone tissues.1,7 
Hydroxyapatite,(HA), Ca10(PO4)6(OH)2 and tricalcium phosphate (Ca3(PO4)2) are some of 
the commonly used bioactive ceramics, which can possibly develop a cohesive chemical 
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bond with bone.26 Accordingly, ceramic materials can be used as a coating onto other 
implant surfaces or it can make up the bulk  of dental implant. 
Inert ceramics like aluminum oxide (Al2O3), carbon (C) and zirconia (ZrO2) are well 
tolerated by bone tissues similar to titanium-based alloys.7 Inert ceramics have high 
strength, stiffness and hardness, but their fracture resistance is poor, especially to bending 
forces. Inert ceramics can withstand relatively low tensile and shear stresses, with the 
high risk of catastrophic fractures.7,17 Several forms of carbon have been used including 
amorphous carbon, carbon fibers and carbon-silicate, but currently they are not used 
because of their defective osseointegration. Alumina, one of the inert ceramics, is brittle 
and tends to break when subjected to occlusal forces.17 
Zirconia is the oxidized form of zirconium (ZrO2). Currently it is the only used all-
ceramic dental implant material, owing to its outstanding mechanical properties 
comparable to that of steel, in particular bending strength, fracture toughness, and 
Young's modulus. Zirconia has been used as implant biomaterial for hip replacement 
since the 1970s.24 In Dentistry; zirconia has been used widely for different applications 
such as manufacturing high strength crown and bridge frameworks, endodontic posts, 
implant abutments, veneers, and orthodontic brackets.7 
The first in vivo study of zirconia dental implants was in 1993, when a group of 
researchers inserted experimental zirconia in the mandibles of dogs.27 However, the first 
clinical report of using zirconia dental implant in patients was published in 2004.28 
Zirconia dental implants showed satisfactory osseointegration that is comparable with the 
titanium dental implants,29 and the stress distribution is also similar to that of titanium 
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implants.30 Other study revealed that the fracture strength of the one-piece zirconia 
implants can be reduced following machining and during cyclic loading.31 Nevertheless, 
the current clinical data on the biomechanical behavior of the zirconia dental implants are 
inadequate.31,32 Currently zirconia is used for different application ranging from dental 
implant abutment, one-piece dental implant, dental posts and in hip arthroplasty (Figure 
1-2). 
 
 
 
 
 
 
 
 
Figure1-2: Clinical applications of zirconia. A) Dental implant abutment. 33 B) One-piece 
dental implant. 34 C) Different generations of zirconia used in hip arthroplasty as bearing 
materials.35 D) Zirconia-containing glass-ceramic ingots and zirconia posts.36 Figures are 
adapted from the references with permission (Appendix A) 
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Zirconia is a polymorphic material since it can have more than one crystalline structure 
depending on the pressure conditions and temperature. Pure zirconia is monoclinic at 
room temperature (RT). As the temperature increases, the monoclinic phase transforms 
into the tetragonal form at 1170 °C and later into the cubic phase at 2370 °C.37 As the 
temperature cools down to RT, phase transformation is accompanied with significant 
volumetric expansion (3-5 vol %) generating high internal stresses and cracks in pure 
zirconia.28,38 
Metal oxides such as CaO, MgO, CeO2 and Y2O3 were added to pure zirconia, in small 
percentages (3-8 mass%), to stabilize the tetragonal phase at RT by allowing the 
generation of multiphase materials and to control the volumetric expansion.38 Yet, the 
majority of dental researches focused on Y2O3 doped zirconia, which is known as yttrium 
tetragonal zirconia polycrystals (Y-TZP).38 Y-TZP exhibits diverse interesting 
characteristics like high density, high compression and bending strength as well as low 
porosity that is usually associated with other oxides such as MgO.37 The addition of small 
percentages of Y2O3 to zirconia results in the formation of a metastable tetragonal crystal 
structure at RT. When a crack is generated, it tends to progress and grow. In the 
meantime, the metastable tetragonal crystal structure of zirconia transforms to the more 
stable monoclinic form accompanied by an expansion of the material causing closure of 
the crack tip and consequently preventing it from advancing.39 This phenomenon is 
known as stress-induced transformation toughening which gives Y-TZP ceramics its 
superior mechanical properties compared with other ceramics. 
On the other hand, the ongoing progression of phase transformation might initiate surface 
flaws, followed by the ejection of grains, resulting in catastrophic effects and making the 
9 
 
material more vulnerable to aging.40 Additionally, Y-TZP undergoes microstructural 
degradation at a relatively low temperature in humid environments leading to a significant 
decrease in flexural strength41 and reducing its functional lifetime as a result of increasing 
the susceptibility to crack growth.42 
Many researchers are concerned about the considerable concentration of radioactive 
impurities of uranium and thorium radionuclides in naturally occurring zirconia.43 Alpha 
and gamma radiations are correlated with zirconia. Significant alpha radiations have been 
detected in zirconia-based ceramics used for surgical implants that can adversely affect 
hard and soft tissue cells.27 Gamma radiation levels are not considered hazardous in 
zirconia.43,44 Since the radioactivity of Y-TZP ceramics can be effectively managed by 
carefully controlled purification procedures, Y-TZP can be safely considered for 
biomedical applications.24,43 Many published papers state that the radiation doses from 
highly purified zirconia powder ceramics form are significantly lower than the natural 
background dose.40 Zirconia can be used as a dental implant by itself, or its particles can 
be used as coating materials for titanium dental implants to improve its 
osseointegration.45 
 1.1.3 Mechanical Parameters of Dental Implant Materials 
Dental endosteal implants are used to reconstruct and replace missing teeth to improve 
mastication, aesthetic and speech, stabilize and support removable dentures or create the 
abutments for fixed prostheses.11 Therefore, the bone-implant interface should withstand 
forces generated during functional and para-functional forces for up to 40 years.17 The 
magnitude and spatial distribution of stresses on the implant, bone and the dental implant-
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tissue interface will depend on several factors: dental implant shape, loading on the 
implant, quality and quantity of the surrounding bone and the mechanical properties of 
implant and interfacial bony tissues.46 Listings of the materials’ physical properties are 
not useful unless they are related to the physiological implications of the biomechanics.47 
Implants are subjected to compression, shear, bending and torsion loading leading to a 
wide range of normal and shear stresses. The force direction must be considered in 
addition to the magnitude of the loading. Since bone is 65% weaker when loaded in shear, 
shear forces that are transmitted from implant to bone should be reduced.13 Increased 
interfacial shear strength results in a better stress transfer from the implant to the 
surrounding tissues and lowers stresses in the implant.48 Studies have shown that 
excessive forces compromise the osseointegration and biointegration of the implants.17 
The occlusal forces are transferred from teeth to the surrounding bone via periodontal 
ligaments as tensile and compressive forces that favor the maintenance of the bone 
support by balancing between bone apposition and resorption in a process known as bone 
remodeling.49 On the other hand, the occlusal loads from the dental implants are 
transmitted to the bone tissues mainly by compressive forces that tend to cause bone 
resorption.4 Modifying the material type, diameter and length of dental implants are 
considered as important factors to reduce the compressive forces in addition to the 
patients’ factors including occlusal habits (clenching and bruxism) and the quality of the 
jawbone.17 Moreover, threaded dental implants have the tendency to reduce shear stress, 
convert occlusal loads into more favorable stresses at the bone interface, and reduce the 
risk of failure.13 
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During normal functioning, dental implants are subjected to various forces and moments 
that are transmitted to its internal structure. Thus they should tolerate these different 
masticatory loads without failures or fracture.50 However, a quantitative evaluation of 
these loads is challenging, because it is determined by several factors such as magnitude 
of the usual chewing forces that range between 220-880 N, anatomical and physiological 
properties of surrounding bone and the mechanical properties of the dental implant.50 
Modulus of elasticity, fracture toughness, fatigue strength, yield and ultimate strengths 
are the more important mechanical properties for dental implant design.1 In the current 
research project, we evaluated the modulus of elasticity and fracture toughness of the 
bioceramics that we synthesized.  
1.1.3.1 Modulus of Elasticity 
The young’s modulus of elasticity (E) is an expression for material stiffness and an 
important property that influences the ability of the implant to transmit stresses to the 
adjacent bone and sustains tissue vitality over time.1 It affects osseointegration and 
implant’s compatibility with surrounding bone.51 The Young’s modulus for titanium and 
dental zirconia are 100-116 GPa10 and 200-210 GPa52, respectively. These values are 
significantly higher than that of the human cortical bone ranging from 4 to 30 GPa.10,11,53 
The extreme mismatch between the E values, of bone and implant materials can lead to a 
phenomenon known as stress shielding. As a result of the extremely stiff implant, disuse 
atrophy, bone resorption and implant complications can occur.54-56 The E value is used to 
evaluate bio-functionality of dental implants. The lower the Young’s modulus of implant 
material, the better the load distribution to the surrounding tissue with the possible 
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beneficial result of new bone formation.11 Porous titanium dental implants are used to 
decrease the E value, but the fatigue strength was diminished by at least 10%.11 
1.1.3.2 Fracture Toughness 
The fracture toughness (KIC) is a measure of energy needed to cause failure in the 
presence of a defect and it is important in evaluating implants with surface contours that 
can act as stress raiser.1 KIC is a critical value of the stress-intensity factors that causes 
failure of the material. KIC values of materials are most useful when working with 
materials of limited toughness or ductility. Materials that show very little plastic 
deformation before fracture usually have relatively low KIC.57 Improvement of KIC values 
of the dental implant materials have been established by various surface modification 
approaches, such as flaw modification (size or geometry), coating and heat treatment.58 
The microstructure of the materials has a considerable effect on the KIC. For instance, 
dense interlocking crystals microstructure usually attributes to higher KIC as a result of 
blunting microcracks and inhibiting crack propagation.36 
KIC is usually measured using a four-point bend test with a single-edge or chevron-
notched specimens or by compact tension through recording the tensile or bending force 
repectively59. Another method for calculating KIC is Vickers indentation tests.57,60 The 
Vickers indentation test has become common for brittle materials like glasses and 
ceramics because it is simple, quick, standardized by using Vickers diamond indenter and 
it can be used on a comparative basis for specimens with small surface area.60 Yet, there 
are limitations to this technique including:  
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1. Presence of 19 different standardized equations in the literature to calculate KIC. These 
equations are assuming the crack geometry as radial-median (halfpenny) or Palmqvist 
shaped.60 
2. Measurement of the crack length, that is used later to calculate the KIC, should be 
accurate and standardized.60 
3. Young’s modulus and hardness of the material should be known to be included in the 
KIC equation.57,61 
Blendell, Evans and Lankford equations applied curve-fitting methods for median and 
Palmqvist crack patterns, which were applicable to both cracks systems.57 In my thesis 
research, the Lankford equation was used to calculate KIC since it combines both crack 
geometries. 
1.1.3.3 Fatigue Strength 
Dental implant materials can fail at a much lower stress, when subjected to cyclic 
loading, than that which the material can withstand under the application of a single 
maximum load. These failures are known in engineering terms as fatigue failures, while 
they are identified in clinical fields as stress fracture. Stress concentration (often known 
as stress raiser or stress riser) is the localization of high stresses at sharp notches, holes or 
corners, it is often the point of originating fatigue failure.62 Once initiated, the crack can 
propagate incrementally within the material under the cyclic or repeated loading.59 Since 
fatigue fracture of dental implants does occur, fatigue resistance is considered an 
important property of dental implants. The most severe mechanical stress conditions are 
related to biodynamic fatigue when several factors are involved such as the surface 
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topography and presence of stress concentration and corrosive environments.59 ISO 
14801 standard was introduced to test the dynamic fatigue strength of dental implant 
materials with angled specimens to determine the survival functional threshold loads 
under “worse case” biological conditions.50 Interestingly, it has been proven that fatigue 
strength especially due to fretting (where an overlapping of friction wears and cyclic 
loading occur between two bodies such as a screw and bone plate) was higher when the 
materials exhibited low Young’s modulus.63 The passive oxide layer on titanium alloys 
can crack when bending forces were applied on the implant leading to corrosion fatigue 
in simulated body environments that accompany low oxygen content and degassing with 
nitrogen.64 It was proven that the fatigue strength of dental implants decreased by 19% in 
simulated body environments compared with the laboratory dry conditions. Furthermore, 
corrosion fatigue can be initiated with the development of pits that act as sites of stress 
concentration.65 
Fatigue failure is infrequent in ceramics owing to the absence of inelastic (plastic) strain 
during cyclic loading.59 However, inter-granular fatigue can cause reduction of 
mechanical strength as a result of the propagation of natural microcracks originally 
existing in the component’s microstructure. Although Y-TZP ceramic materials show 
significant subcritical crack propagation at extensively lower stress levels, but it could be 
used successfully in dentistry subjecting to the masticatory forces taking into 
consideration its initial high mechanical strength and special design of the material.66 
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1.2 GLASS-CERAMICS 
Glass-ceramics (GC) were first discovered in mid-1950s by a famous glass chemist, S.D. 
Stookey36 who found that these materials combined the attractive properties of glasses 
and ceramics on top of the favorable properties superior to organic polymers and 
inorganic materials.36 Later, in the late 1950s, Corning Glass Works developed diverse 
GCs for different applications.39 MacCulloch7,39 in 1968 introduced the first dental GC 
based on the Li2O-ZnO-SiO2 system that was used to construct denture teeth. He 
suggested the possibility of using this GC to fabricate crowns and inlays by centrifugal 
casting of molten glass.39 
GC is a ceramic material formed by a process called ceramming. This process involves 
subjecting base glasses to controlled heat treatment, during which nucleation is initiated 
followed by the development of tiny and evenly distributed crystals throughout the glass 
structure. The crystalline phase will grow and can eventually occupy from 50% to nearly 
100% of the material.7,39 Thus, a GC is a multiphase material containing a residual glass 
with a finely dispersed crystalline phase(s).39 The number and size of the crystals and 
their growth rate are regulated by the ceramming time and temperature of the heat 
treatment. GCs have a wide variety of special microstructure that cannot be produced in 
any other material. These microstructures are related to the base glass, structure of the 
formed crystals and their mode of growth.39 Currently, GCs based on leucite, lithium 
disilicate and HA have been used for dental applications. They are available as powders 
or as solid blocks that can be pressed, milled or prepared using computer-aided 
design/computer-aided manufacturing (CAD-CAM) technology. 
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1.2.1  Glass-Ceramic Properties 
GCs with diverse and favorable properties were developed based on the chemical 
composition of the base glass and the microstructure of the GC. Regarding the processing 
properties; synthesis of parent glass is considered as a critical step in the GC 
development. In addition to producing bulk glasses by traditional melting and forming, it 
can be produced by sol-gel, chemical vapor deposition, rolling, spin-casting, thin-layer 
method, casting, drawing, pressing and press-blowing a glass melt. Technologies used to 
synthesize the base glass can be used for the production of the GC. Glass powder or 
grains can be converted to GCs by different methods. GCs are thermally stable; they can 
withstand high-temperature with limited and controllable shrinkage and expansion. Thus, 
GCs are manufactured on a large scale for industrial, technology and medical 
applications.36 
As GCs are non-porous and multi-phase materials, they demonstrate different levels of 
translucency, transparency, and opacity based on the type of crystals, microstructure of 
the material and the difference in the refractive index between the crystal and the parent 
glass.67 GCs can be produced in any color by adding pigmentation. Other important 
optical properties for some GCs are fluorescence and opalescence.36 
Degradable or chemically durable GCs can be produced depending on their crystals, the 
glass and crystalline phases exist in the material and the interface between the crystals 
and the glass phase. Different microstructures of GCs permit the combination of 
resorbability of one specific phase and chemical stability of other phase(s). Some GCs 
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have good biocompatibility and have been developed for medical and dental applications; 
other GCs are bioactive and used in implantology.68 
The mechanical properties of GCs are improving; it has been possible to achieve flexural 
strength up 500 MPa and KIC higher than 3 MPa·m0.5. Flexural strength (also known as 
bend strength, fracture strength or modulus of rupture) is the material’s ability to resist 
deformation under load when unsupported, while the fracture toughness is the estimation 
of the load required to cause crack propagation.62 No other material exhibited excellent 
mechanical properties combined with translucency and handling qualities as in the case of 
monolithic GCs. An additional advantage of certain GCs is their machinability, where the 
material can be milled, drilled or sawed into different shapes.69 Furthermore, surface 
characterization of the GCs such as roughness, polishability, luster or abrasion can be 
controlled.68 There are different GC systems, which are available in the market for 
medical or dental applications such as wollastonite, leucite, lithium disilicate, HA and 
mica GCs. Other GC systems are discussed in the literature but they are still not available 
for clinical applications such as miserite, fluorrichterite, fluorapatite and canasite GCs.36 
1.2.2. Medical Glass-Ceramics 
GCs are used in implantology as medical prostheses to replace missing parts of body such 
as orthopedics, head and neck surgery, dental implants and root fillers. These materials 
should be biocompatible, and in most cases, bioactive to form a biologically active 
hydroxycarbonate apatite (HCA) layer that permits bonding with bone. Depending on the 
application, GC can be load bearing or non-load bearing to fulfill different requirements 
for each situation with respect to bending strength, toughness and Young’s modulus.36 
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Bioactive glasses such as BIOGLASS® was found to have multiple applications and are 
used in head and throat surgery in the form of middle-ear devices and implants for orbital 
floor of the skull.25 The following bioactive GCs are used in human medicine for 
implantology: Cerabone®, Ceravital® and Bioverit®. 
Cerabone® is a GC prepared from the parent glass in 3CaO.P2O5-CaO.SiO2-
MgO.CaO.2SiO2 system. Both of, apatite (A) and wollastonite (W) crystalline phases are 
homogeneously distributed in a glass matrix, commercially known as cerabone®A-W.70 
Cerabone®A-W is the most widely and successfully bioactive GC used for bone 
replacement in human medicine.36 Since 1983, A-W GC has been used in spine and hip 
surgery, in the form of vertebral prostheses, for iliac crest restorations70 or as bone defect 
fillers.36 A-W GC demonstrates high bioactivity.70 The advantages of this GC provided by 
the combination of bioactivity and specific mechanical properties, such as compressive 
strength (215 MPa), Young’s modulus (110 GPa) and KIC (2 MPa·m0.5).36 The GC can be 
used in non-bearing load areas, and it was successfully used for vertebra replacements in 
more than 10,000 patients between 1991-1996.36 
Ceravital® Apatite-devitrite GC contains mainly SiO2, Ca(PO2)2 and CaO with small 
amounts of oxides such as Na2O, MgO, K2O.70 In vitro and in vivo investigations have 
proven the biocompatibility and bioactivity of ceravital® GC.71,72 However, because of its 
poorer mechanical properties, the only clinical application for this material is the 
replacement of the ossicular chain in the middle ear where the loads are minimal.36,70 
Bioverit®I is a mica-apatite GC with a chemical composition derived from the SiO2-
Al2O3-MgO-Na2O-K2O-F-CaO-P2O5 base glass system. Bioverit®II GC contains mica as 
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the main crystal phase. Bioverit®III is SiO2-free, contains apatite, AlPO4 and complex 
phosphate structure.70 All these GCs are machinable and workable with standard metal 
tools and they can be modified during the surgical procedure. The machinability of these 
GCs depends on mica content and the morphology of the GCs – the higher mica contents 
the better machinability of the GC.36 Adequate mechanical properties of Bioverit®I and 
Bioverit®II allow them to be used as medical bone substitution for different applications 
such as orthopedic, head and neck surgery especially middle ear implants. Bioverit®III is 
used in composites with certain metals as bioactive materials.70  
1.2.3  Dental Glass-Ceramics 
Dental GC is the second category of GCs that used for restorative dental applications to 
fulfill the dental biomaterial standardization. They must be capable of simulating the 
natural teeth properties: show compatibility with oral environment, high strength, 
resistance to abrasion and wear, and excellent chemical durability to withstand the harsh 
oral circumstances of wide range of temperature and pH. Surface properties of the dental 
GCs should match those of natural teeth like shade, translucency, opalescence and 
fluorescence. Another important property of the dental GCs is their suitable handling 
techniques for both dentists and dental technicians.73 
Restorative dental materials are used to fabricate crowns, bridges, inlays, onlays and 
veneers by different techniques such as casting, hot pressing, moulding, centrifuge 
layering and sintering.74-76 The following dental GCs have these properties: Dicor®, IPS 
Empress® Cosmo, IPS Empress®, IPS Empress® 2, IPS d. SIGN®, Pro CAD® and IPS 
e.max. 
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Dicor® was the first GC used for inlays and crowns production68 synthesized from SiO2-
Al2O3-MgO-K2O-ZrO2-CeO2 glass system.36 The main crystalline phase present in this 
GC is tetrasilicic mica crystals produced by controlled volume crystallization. Crystals 
are 1 µm in length at approximately 55 vol %.75,77 Dicor® is a castable GC with which 
dental restorations are fabricated in the dental laboratory in a centrifugal casting 
procedure.68 The optical quality of DICOR® produced by controlled translucency is based 
on the microstructure of mica crystals embedded in a glassy matrix.36 There is a 
relationship between the clinical survival of Dicor®GC dental restorations (up to 20 years) 
to various physical and biological factors, such as tooth position, patient sex, core 
structure, acid etching and cementation.78 
Dicor®MGC is a machinable GC, where the dental restorations are produced using CAD-
CAM technology. This GC is characterized by a high crystallinity, approximately 
70 vol % of crystal content. The main crystalline phase is tetrasilicic fluromica, 
KMg2.5Si4O10F2, in a sandwich-like composite sheet.36,74 Interlocking, easily cleavable 
fluoromica flakes of average diameter of 2 µm and 0.5 µm thickness, are the key 
machinability factors in the microstructure of Dicor®MGC.36,69 Dicor®MGC have 
excellent properties, yet their clinical application is limited due to low KIC 
(1.5 MPa·m0.5)79 and low biaxial flexure strength (150 MPa).80 
IPS Empress®Cosmo is used for dental core construction where its strength is improved 
by incorporation of more than 15% ZrO2 in P2O5-SiO2-Li2O-ZrO2 base glass. The 
properties of GCs are influenced by the growth and formation of ZrO2 rich (Li2ZrSi6O15) 
crystals during the hot-press procedure. These GCs demonstrate a bending strength of 
maximum 160 MPa with high translucency.81 Two different materials: IPS 
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Empress®Cosmo and ZrO2-sintered ceramic (CosmoPost) are used as a unique 
combination to form post and core for endodontic treated teeth. The advantages of using 
post and core combination include: improved esthetics, unified post and core, inert and 
stable materials, high bending stiffness resistance to fatigue loading and simple 
fabrication procedures.82 
IPS Empress® is an extremely homogeneous, leucite-based material (KAlSi2O6) 
fabricated from the SiO2-Al2O3-K2O base glass system using surface controlled 
crystallization.74 The degree of crystallinity of IPS Empress®GC is 35±5 vol %.83 Leucite 
crystals increase flexural strength of the GC; the GC exhibited biaxial flexural strength of 
110-160 MPa36,83 and KIC up to 1.3 MPa·m0.5.83 Flexural strength value can be increased 
to 200 MPa, by improving the surface quality74 or by modifying its microstructure.84 The 
GC demonstrates very good chemical durability, optical properties (Figure 1-3A), 
abrasion and wear resistance qualities, that are comparable to those of natural teeth.76 
From 1991-2004, this GC was used to produce 27 million dental restorations, and the 
success rate was higher than 90% over 14 years of clinical assessment.68 However, the 
fracture rates were higher for posterior crowns than the anterior ones for different time 
periods ranging between 5-11 years.76,85 Consequently, IPS Empress® is recommended 
for producing metal free dental restorations such as inlays, onlays, crown and veneers, but 
not recommended for multi-unit dental bridges.36 
IPS Empress®2 is a pressed GC with lithium disilicate (Li2Si2O5) crystal phase. It was 
developed in order to overcome the limitations of IPS Empress®, by increasing its 
strength and toughness to extend the clinical applications to posterior multi-unit bridges.75 
The pressed GC is derived from the basic SiO2-Li2O system with other oxides additions 
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such as ZnO, P2O5, K2O and La2O3. It is fabricated through a combination of the lost-wax 
and heat-press techniques. The GC has high crystal content (Figure 1-3B). Lithium 
disilicate crystals are precipitated in the base glass by epitaxial nucleation and 
crystallization until they reach up to 70±5 vol %, with randomly oriented interlocking 
microstructure that are attributed to its superior mechanical properties.9 The interlocking 
crystals deflect and blunt the developing cracks leading to increasing the toughness of the 
material75 and substantial increasing in the flexural strength.39 The mechanical properties 
of lithium disilicate GC are double or triple those of leucite GC.83 The flexural strength 
value of IPS Empress®2 is around 400 MPa and the KIC is about 3.3 MPa·m0.5.83 
Moreover, the chemical durability of this GC is within the ISO requirements of dental 
ceramics and it is better than IPS Empress® GC by about fourfold.83.Though, the GC 
cannot be machined or cut after pressing.68 
IPS e.max Ceram is a low fusing nano-fluorapatite GC, and it is applied as veneering of 
restoration produced by press technology and/or CAD-CAM technology to improve its 
optical properties. Apatite needle-like crystals can be precipitated in SiO2-Al2O3-CaO-
Na2O-LiO2-K2O-P2O5-F system.68 The abrasion characteristics of the fluorapatite-
containing GC are similar to lithium disilicate GC, but its chemical durability is higher 
than IPS Empress®2. Dental restorations can be fabricated in a special combination 
design; framework made of the high strength GC to absorb the load peaks, and the veneer 
apatite GC to produce optical properties such as fluorescence and opalescence with 
excellent chemical durability.36 
IPS d.SIGN®: a leucite-apatite composite containing GC derived from the SiO2-Al2O3-
Na2O-K2O-CaO-P2O5-F system. This GC is developed by combining two different 
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mechanisms: controlled surface nucleation that precipitates leucite crystals, and controlled 
bulk nucleation that precipitates fluoroapatite crystal phase, Ca5(PO4)3F.68 It is used to 
veneer metal framework of multi-unit bridges owing to the combinations of appropriate 
translucency, color, and brightness, with proper mechanical and chemical properties.75 
This GC is the most frequently used GC materials; around 55 million units were clinically 
delivered from 1998-2004.68 IPS d.SIGN® GCs can be presented in different categories 
according to their usage to restore different tooth structures.36 
Figure 1-3: Dental applications of glass ceramic A) IPS Empress®GC inlays and veneer. 
B) IPS Empress®2 (3 unit bridge, crown, veneer and inlay). Adapted with permission 
from Glass-Ceramics Technology.36 (Appendix A) 
1.2.4 Machinable Dental Glass-Ceramics 
CAD-CAM has become a commonplace fundamental technology in an industry used to 
design and fabricate virtually various products such as automobile, airplanes and jet 
engines.86 CAD-CAM was introduced to dentistry in 1970s, followed by the development 
of CEREC® system in 1980s.87 CAD-CAM provides advanced, highly qualified, state-of-
the-art services to dental patients.88 
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Machinable dental materials can be milled into their final form without condensation, 
sintering or melting. For direct restoration, a camera scans the replica of the prepared 
tooth to produce digital impression. Data are processed to software that guides machining 
tools to mill the ceramic blocks to the final restorations within a short time. Dental 
restorations are delivered in a single clinical appointment minimizing postoperative 
sensitivity and preventing tooth contamination. In the most advanced techniques, captured 
digital impressions are sent electronically to the lab for milling and production of the 
restorations. CAD-CAM restorations have several advantages over other restorations. 
First, shrinkage is not associated with CAD-CAM restorations due to the absence of 
heating, casting, condensing and melting. Second, the properties of the restorations are 
more predictable because of the machinable dental blocks.17 Currently, the innovation of 
CEREC®3 system is reflected in technical improvement of processing quality of ceramic 
restorations that are produced with natural morphology, fine surfaces and improved 
adaptation to the restored teeth.89 
ProCAD®: is a leucite-reinforced GC derived from the system SiO2-Al2O3-K2O-Na2O, 
similar to IPS empress® with a finer particle size. It is characterized by excellent chemical 
durability, outstanding esthetic outcomes with different degrees of translucency that is 
available in several shades.90 Mechanical properties of ProCAD® are acceptable, KIC was 
determined to be 1.3 MPa·m0.5 with flexural strength of 135-160 MPa, that may be as high 
as 180-240 MPa after polishing the restoration surface or applying ProCAD® glaze.36 
IPS e.max®: is a machinable lithium disilicate GC that can be used with CAD-CAM 
systems. An intermediate lithium metasilicate GC containing dendritic crystals was 
developed, where the crystals are smaller and more homogenous than lithium disilicate.91 
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Lithium metasilicate GC is blue in color, and it can be machined easily and quickly to 
produce dental restorations which subsequently are heat-treated at 850 °C to be converted 
into a lithium disilicate GC. Subsequently, the restorations are additionally veneered with 
a fluoroapatite GC to imitate the optical properties of natural teeth.92 Clinical studies 
reviewing IPS e.max® dental restorations showed up to 8 years survival rates up to 93% 
for dental crowns and small bridges.93 Other clinical studies disclosed that IPS e.max® 
all-ceramic three-unit bridges exhibited survival and success rates comparable to those of 
metal-ceramic bridges.91 
1.3 BONE PROPERTIES FOR DENTAL IMPLANTOLOGY 
Bone is a highly organized, mineralized connective tissue that has fundamental physical 
functions. It is one of the few mammalian tissues that can resist compressive and shear 
loading. Because of its stiffness and rigidity, it is suited for different functions including 
locomotion, standing and withstanding the mastication forces that can reach 1000 N.94 
Two primary functions are provided by bone: mechanical and metabolic. From the 
mechanical point of view, bone supports different structures and organisms, protects vital 
organs such as brain and heart and acts as leverage for musculoskeletal locomotion.95 
Bone consists of a biphasic extracellular matrix (ECM), cells, blood vessels and nerves. 
Bone matrix is composed of 30 vol % organic and 70 vol % inorganic materials.96 The 
organic part consists mainly (98%) of a network of collagen type I fibers that contribute 
to tensile strength and toughness.97,98 The remaining 2% of the organic content includes 
structural and biologically active proteins, glycoproteins, peptides, lipid materials and 
adsorbed serum proteins.95 The inorganic portion of bone ECM is composed of minerals, 
primarily carbonated hydroxyapatite, that include a complex of calcium phosphate, 
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calcium carbonate and small amounts of calcium fluoride and magnesium fluoride4 that 
contribute to compressive and shear strength and hardness.97 The crystals in bone are 
small (an approximate diameter of 25-75 Å and length of 200 Å), and primarily presented 
in the form of poorly crystalline carbonate-apatite structure.95 
1.3.1 Macroscopic Structure of Bone 
The mammalian skeleton is composed of two distinct kinds of bone based on porosity: 
dense cortical bone (also known as compact bone) and trabecular bone (also known as 
spongy or cancellous bone). Both cortical and trabecular bone are found in every bone 
site, but their quantity and distributions vary. The non-mineralized spaces within 
trabecular bone contain marrow, blood vessels, nerves and various cells. The main 
function of marrow is to generate the cells present in blood. Marrow is a highly 
osteogenic tissue that can lead to bone formation if placed in extracellular skeletal 
locations.4 
Dense cortical bone comprises about 80-85 vol % of total bone in the body, it forms a 
shell around vertebral bodies and most bones. Cortical bone has two surfaces: outer 
periosteal and inner endosteal surfaces49 (Figure 1-4). Cortical bone is organized in bony 
cylinders consolidated around a central blood vessels, called a Haversian system or 
osteon.4 The structure and microstructure of cortical bone provide the principal 
mechanical strength of the skeleton; the cortical thickness and cross sectional areas are 
strong indicators of gross bone strength and fracture resistance.97 Trabecular bone 
comprises about 15-20 vol % of the body’s total bone, is found in cuboidal, flat bones and 
in the end of long bones. When compared with cortical bone, it is lesser in density and 
has a greater degree of macro-porosity (medullary cavities) that is interconnected and 
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filled with hematopoietic marrow or fatty marrow in older adults.  
Periosteum, the outer surface of cortical bone, forms a boundary between bone tissue and 
the covering soft tissue. The endosteum is fibrous and delicate membrane consisting of 
progenitor cells with slight amount of connective tissue. It acts as a lining of medullary 
and inner cavities of bone. Periosteum and endosteum are the sites of metabolic, cellular 
and biomechanical activities that modulate bone growth and shape.49 They also contribute 
to new bone formation in the case of bone fracture.96  
Wolff’s law stated that there are specific strain values that maintain the form and mass of 
the bone; values above this range will stimulate bone apposition while strains below the 
maintenance limit lead to bone resorption.99 A study showed that these dynamic changes 
in the alveolar ridges primarily occur in cortical bone.100  
1.3.2 Bone Cells 
A brief overview of bone cells is provided in the thesis because knowledge of the role of 
different bone cells and matrix molecules in bone formation and resorption is important 
for understanding the body’s reaction to dental implants. This knowledge is helpful for 
evaluating the biological performance of different materials used as dental implants. 
Three major types of cells are involved in bone metabolism and physiology: osteoblasts, 
osteocytes and osteoclasts (Figure 1-5).  
Osteoblasts are mononuclear, cuboidal and highly secretory cells. They are derived from 
multi-potential mesenchymal progenitor cells; mesenchymal stem cells or marrow-
derived stromal cells.95 Mature osteoblasts are responsible for producing bone’s organic 
matrix that subsequently mineralizes extracellularly.101  
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Bone deposition continues in an active growth area, with osteoblasts laying down new 
bone in sequential layers. Osteoblasts produce phospholipids and proteoglycans that are 
important in the mineralization process.4 They produce paracrine growth factors that 
influence osteoprogenitor cells, the growth of preosteoblasts, and resorption of the 
mineralized bone matrix by osteoclasts during bone remodeling.95 Mature osteoblasts 
affect osteoclastogenesis that in turn controls the degree of resorption at different bone 
sites.103 Moreover, osteoblasts may act as helper cells for osteoclasts during normal bone 
resorption.4 When osteoblasts have successfully produced bone matrix, a fraction of 
osteoblasts that had become embedded transform into osteocytes, while the majority of 
the cells undergo programmed cell death (apoptosis).95  
Osteocytes are mature, post-synthetic osteoblasts; they are the most abundant bone cells 
(90-95% of all bone cells) and are the longest living type of bone cell.104 Osteocytes are 
involved in mineral homeostasis95 and coordination of metabolic activities.104 Osteocytes 
act as mechanosensory cells by responding to internal and associated local strains from 
external loads on bone and, thus, osteocytes help to sustain the ECM.96 Mechanical 
stimulation regulates gene expression in osteocytes, and affects their survival and 
apoptotic death. Some studies indicated that osteocyte apoptosis might stimulate or inhibit 
signals regulating the localized function of osteoclasts and osteoblasts.105 Additionally, 
osteocytes can induce osteoclast activity, where the osteocytes orchestrate bone 
resorption as a result of expression of a rate-limiting factor required for osteoclast 
formation and function.104,106 
Osteoclasts are large motile, multinucleated cells (containing as many as 50 nuclei), and 
are responsible for bone resorption.4 They originate from hematopoietic stem cells in the 
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non-adherent part of the bone marrow.107 Osteoclasts are located in shallow excavations 
(Howship’s lacunae) along mineralized bone surfaces.4 The mechanism of the 
osteoclastic bone resorption is unique and efficient. Bone resorption requires a number of 
steps: 1) migration of osteoclast precursors to the bone surface; 2) fusion of precursors to 
form multinucleated osteoclasts; 3) attachment of the osteoclast to the bone surface; 4) 
polarization of the osteoclast to form three distinct membrane domains – a ruffled border, 
a sealing zone and a functional secretory domain; 5) pumping of HCl to lower the pH in 
the resorption lacuna, leading to dissolution of bone mineral; 6) secretion of hydrolytic 
enzymes to degrade the organic phase of the bone matrix; and 7) removal of degradation 
products from the resorption lacuna. Afterwards, osteoclasts undergo apoptosis or return 
to the non-resorbing stage.108  
In healthy adults, there is a continuous balanced interaction between bone-forming 
osteoblasts and bone-resorbing osteoclasts to sustain skeletal remodeling and maintain 
bone mass. Discrepancies of this balanced relationship are a feature of pathological 
disorders such as osteoporosis.95 
Bone-lining cells are a fourth type of bone cells. They are retired osteoblasts that do not 
embed in newly formed bone like osteocytes; instead, they adhere to the outer bone 
surfaces. Bone-lining cells are responsible for regulating the transfer of mineral ions in 
and out of bone, for sensing mechanical strains and for initiating bone remodeling in 
response to various chemical or mechanical stimuli.4 Bone-lining cells also have 
important function of cleaning bone surfaces before osteoclastic resorption.109 
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1.3.3 Bone Related Markers and Adhesion Proteins 
Different ECM molecules and other proteins have been proposed in the literature as bone 
markers. Cell-dental implant interactions such as cell attachment, adhesion, proliferation 
and differentiation involve collagen I, alkaline phosphatase, osteopontin, and bone 
sialoprotein.110 It is important to understand the expression of specific bone-related 
markers, involved in osteoblast development, osseointegration and dental implant 
biocompatibility. Below, we briefly discuss the marker that was used in this thesis as well 
as the adhesion proteins used to assess osteoblast attachment and spreading.  
Alkaline phosphatase (ALP) is a hydrolytic enzyme that removes phosphate groups 
from proteins and other types of molecules. It is present in bone (produced by 
osteoblasts) and several other organs of the human body. ALP is a common biochemical 
marker used to evaluate osteoblast differentiation111 and is considered as a sensitive and 
reliable indicator of osteoblast activity.112 It can be bound to the surface of osteoblasts via 
a phosphoinositol linkage and can be free floating within the mineralizing matrix.49 ALP 
is abundant in matrix vesicles that are thought to contribute to ECM calcification113. The 
levels of ALP are increased before bone mineralization to generate free phosphate 
(needed for formation of HA) and to degrade mineralization inhibitors such as 
pyrophosphate.111 
Adhesion proteins: Cell adhesion on implant materials is required for successful 
osseointegration of the implanted material. Moreover, cell adhesion to ECM is crucial for 
modulation of numerous critical cellular events; examples include gene expression, cell 
locomotion and subsequently cell differentiation, proliferation and survival.114 Cell 
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adhesion is dependent on integrin-mediated signal transduction and cytoskeleton proteins 
that form specialized structures known as focal adhesions (FA).111 At FA sites, bundles of 
actin filaments are attached to transmembrane receptors of the integrin family. Some FA 
components provide a structural link between actin filaments and membrane receptors. 
Other components are signaling molecules including different protein kinases and 
phosphatases, their substrates and many adaptor proteins. These complexes include focal 
adhesion kinase, vinculin, integrins and actin filaments. 115 
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Figure 1-4: Sections through the diaphysis of a long bone, from the periosteum on the 
right, to compact bone tissue in the middle, to spongy bone tissue and the medullary 
cavity on the left. The inset at the upper right shows an osteocyte in its lacuna. 
Reproduced from Anatomy and Physiology: From Science to Life, 2nd edition with 
permission of John Wiley & Sons, Inc.102 (Appendix A). 
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Figure 1-5: Schematic view of a cross-section through the mandible. An outer cortical 
shell encases the inner trabecular bone containing the hematopoietic elements. When 
examined at higher magnification, as in the upper drawing, the various cellular elements 
of bone (osteoblasts, osteoclasts, osteocytes and bone lining cells) may be identified. 
Adapted with permission from Dental Implant, 2nd edition6 (Appendix A). 
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1.4 OSSEOINTEGRATION OF DENTAL IMPLANTS 
Osseointegration is the formation of a direct interface between an implant material 
surface and the host bone tissues without intervening connective tissue.116 Brånemark117 
developed the concept of osseointegration in the 1950s when he discovered the formation 
of strong bond between bone and titanium. The bone-implant interaction and the 
conditions that favor osseointegration depend on various factors: implant material, 
implant design and shape, chemical and physical surface quality, status of the bone, 
surgical technique, and mechanical loading conditions.118,119 For a successful 
osseointegration, the implant must be inserted with a low-trauma surgical technique to 
avoid bone overheating during preparation of the precise recipient site. Implant must be 
placed with initial stability and should be non-functional during the healing period of 3-6 
months.2  
Interfacial micromotion is a periodic development of µm displacement of an implant 
body relative to the surrounding tissue as result to a shear or tensile force.120 Micromotion 
has destructive effects on osseointegration; it will replace the early bony healing process 
by scar tissues through damaging the fibrin network and the new vasculature.121 The long-
term osseointegration of dental implants relies on their placement within bone that has 
adequate trabecular density, ridge height and width. Trabecular bone that is not 
sufficiently dense will either fail to osseointegrate or lose its osseointegration over time.4 
Many researchers showed that surface modification and roughness of dental implants 
such as porous plasma-spray,26,122 sand blasting,122,123 ultraviolet treatment,124 acid 
etching125,126 or anodic oxidation13 have direct effects on cellular proliferation and 
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differentiation. Other studies revealed that porosity provides favorable environments for 
bone interlocking and in-growth. Titanium implants with a micro rough surfaces 
accomplish faster bone integration and superior percentage of bone implant contact with 
shorter healing periods compared with titanium implants with a polished or smooth 
surface.3,119,122,125 It has also been demonstrated that surface treatments such as 
biomimetic coatings (e.g. calcium phosphate) promote greater osseointegration.14,116,125 
Ceramic implants promote biointegration versus osseointegration that are related to 
titanium-based dental implants. Successful osseointegrated/biointegrated dental implants 
should show clinical stability without any kind of mobility that can be maintained 
throughout the lifetime of the implant. Biointegration can be defined as the continuity of 
ceramic implant to the surrounding bone without any intervening space.17 In this case, 
corrosion products will enclose the implant surfaces and there will be a chemical bond 
between the implant material and the bone.127 
Biointegration, although not fully understood, is considered to be a chemical degradation 
of the ceramic material that integrates with the surrounding bone and stimulates bone 
formation. Yet, the advantages of biointegration over osseointegration are not clear, but in 
both cases, surrounding bone should remain vital.17 To combine both osseointegration and 
biointegration properties at the osteotomy site, plasma-spray coating of HA is used as the 
most common method for surface modification of metallic dental implants with a coating 
thickness of 50-100 µm.26,45,128 In this case a combination of high strength alloy and 
favorable biointegrated characteristics of the ceramic material is achieved.17,25 These 
bioactive coatings will enhance bone apposition and reduce healing time.129 Many studies 
disclosed that these ceramic coatings promote greater bone-implant contact and 
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biointegration rather than osseointegration and showed a greater bone-implant 
contact.5,130,131  
The bond strength of ceramic coatings to alloys is a significant concern. For example, 
some studies have observed that non-uniform and partial degradation of the ceramic 
coatings interferes with the cellular reactions at the implant-bone interface.132 Other 
studies considered the coating dissolution as an adverse factor on the long-term 
integration of the dental implants.129,133 Debonding of the coatings from the base alloys 
could affect the long-term performance of the implant.14 The mismatch of the Young’s 
moduli between the implant and the coating material can cause local loading with high 
stress value at the interface leading to a reduction in the fatigue stress of the implant.65 
It is advantageous to accelerate bone apposition onto dental implant surfaces because a 
steady interface must be achieved before starting the implant loading. Different implant 
surface configurations can improve the osseointegration, leading to the full transfer of 
occlusal loads to the adjacent tissue and minimizing relative motion between implant and 
bone to avoid creation of fibrous integration, thereby lengthening the service life of the 
implant.13,118 
1.5 BIOACTIVITY IN DENTAL IMPLANTOLOGY 
There is a group of glasses and GCs that exhibit bioactivity by bonding to living bone 
with the formation of an apatite layer. Bioactive materials are used clinically for the 
replacement and reconstruction of bone defects resultant from diseases or trauma.134 To 
assess the bioactivity of biomaterials, in vitro testing is usually carried out to confirm the 
formation of HA layer on the material surfaces. Kokubo et al135 and Hench et al136 
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introduced acellular solutions with ion concentrations nearly equal to those of human 
blood plasma known as simulated body fluid (SBF), but they are richer in Cl− ion and 
poorer in HCO3− (Table 1-1). 
Table 1-1: Ionic compositions (in mM) of human blood plasma and SBF.137 
Ion Na+ K+ Mg2+ Ca2+ Cl- HCO-3 HPO42- SO42- 
Human blood plasma 142.0 5.0 1.5 2.5 103.0 27.0 1.0 0.5 
SBF 142.0 5.0 1.5 2.5 147.8 4.2 1.0 0.5 
 
Many researchers have used SBF to investigate the bioactivity of biomaterials. 
Specimens are soaked in SBF at body temperature for different time-points, and the 
material surfaces are investigated later. A material that shows apatite formation on its 
surface in SBF in a short time, usually bonds to living bone.137 
The mechanism of bioactivity is time-dependent as discussed in the literature. Several 
stages are included in this mechanism: 25,138 
i. Rapid exchange of Na+ or K+ with H+ or H3O+ from the solution. 
ii. Loss of soluble silica in the form of Si(OH)4  to the solution, resulting from 
breakage of the Si-O-Si bond and formation of Si-OH (silanols) at the material 
solution interface. The SiO2-rich layer is condensed and repolymerized on the 
surface depleted in alkalis and alkaline cations.  
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iii. Ca2+ and PO43− groups are migrated to the material surface through the SiO2-rich 
layer to form a CaO-P2O5-rich film on top of the SiO2-rich layer.  
iv. Amorphous CaO-P2O5-rich film grows by incorporation of soluble calcium and 
phosphates from SBF.  
v. Finally, Amorphous hydroxycarbonate apatite (HCA) film crystallizes by 
incorporation of OH−, CO2−, or F− anions from the solution.  
The last two stages are critical for controlling the biological activity of different 
biomaterials. If these stages are extremely slow, the material is considered as non-
bioactive because there will be little or no bonds formed on the surface of bone. On the 
contrary, in a case of a very fast reaction, a resorption will be observed and the material is 
considered as biodegradable and resorbable. With a bioactive material that exhibits bone-
bond formation, these stages must closely match the time of bone biomineralization.25 
The process of apatite formation can be characterized by different tests such as X-ray 
diffraction (XRD), Fourier transform infrared reflection spectroscopy (FTIR), energy 
dispersive X-ray spectroscopy (EDX) and scanning electron microscopy (SEM). Studies 
showed that apatite started to nucleate on the silica gel layer, and then they grew to make 
a spherulitic form by consuming the calcium and phosphate ions from the surrounding 
fluid. Each spherulitic structure consisted of plenty of flakes of HCA. The Ca/P ratio of 
the apatite was estimated around 1.5-1.6. Thus, the apatite formed was able to induce 
secondary nucleation of the apatite.139 
The commercially available dental implants (titanium and zirconia) are bioinert. Several 
bioactive materials such as BIOGLASS® 140 HA and wollastonite130,141 have been used as 
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coatings on the implant substrate, to modify their surfaces and make them bioactive. 
Various techniques have been used to prepare the bioactive coatings like plasma-
spraying,130 micro-arc oxidation,142 electro-hydrodynamics spray deposition, sputter 
technique,143 sol-gel and vacuum deposition.14 There are some limitations to bioactive 
coatings. They could fail during cooling from the fabrication temperature, under service 
stresses, or due to lack of adhesion between the coating and the substrate.144 Some coating 
materials such as HA exhibited microstructural changes that lead to a very slow 
osseointegration rate and could jeopardize the long-term stability of an implant.141 
The development of bioactive GCs for dental implant applications with suitable 
mechanical properties is considered as a substantial challenge for researchers and yet 
remarkable progress in the dental implantology field is occurring. The motivation of this 
research is to synthesize bioactive, machinable and biocompatible with suitable 
mechanical properties as an alternative to metallic non-bioactive dental implant material. 
1.6 THESIS HYPOTHESES AND OBJECTIVES 
The overlying hypothesis of this study is that GCs can be synthesized with properties 
suitable for use in non-metallic, one-piece dental implant applications. In particular, our 
aim was to produce bioactive, biocompatible and machinable GCs that exhibited 
appropriate mechanical, physical, optical and chemical properties to overcome the 
limitations associated with current commercial dental implant systems (titanium or 
zirconia). We also hypothesized that one could synthesize transparent precursor glass 
with wet chemistry methods and then sintering the glass powder to produce GC. A further 
hypothesis was that modification of glass composition and heat treatment schedules 
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would improve the mechanical, physical and chemical properties of resultant GCs. 
Overall, we proposed that multiphase GCs constituted of miserite or wollastonite as the 
main crystalline phases are suitable materials for non-metallic, one-piece dental implant 
applications owing to their superior mechanical properties, excellent chemical durability, 
machinability, osteogenic potential and biocompatibility. 
In order to test these hypotheses, the specific objectives of the research were: 
1. To fabricate dental transparent glasses in different systems by wet chemistry. 
2.  To study the crystallization kinetics of the glasses. 
3. To synthesize a miserite GC by cold pressing and sintering, and to characterize its 
mechanical, physical and biological properties. 
4. To investigate the effect of modifying heat treatment schedules on the mechanical 
properties of miserite GC. 
5. To synthesize a wollastonite GC by cold pressing and sintering, and to characterize its 
mechanical, physical, chemical and biological properties. 
6. To investigate the effect of modifying the parent glass chemical composition on the 
mechanical and chemical properties of wollastonite GC. 
1.7 THESIS ORGANIZATION 
The work presented in this thesis focuses on synthesis and characterization of novel GCs 
for dental implant applications. Chapter 1 presented the rationale, background and 
pertinent literature review. Chapter 2 (Saadaldin et al145) describes the synthesis of base 
glass, characterization of the crystallization kinetics of the glass, and synthesis of four 
GCs from the glass powder using different heat treatment schedules. Characterization of 
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the crystalline phases, microstructure, mechanical properties and machinability of the 
GCs are presented. Finally, testing bioactivity in SBF and biocompatibility (osteoblast 
morphology, attachment and proliferation) of the miserite GC that exhibited the best 
mechanical properties are presented. Chapter 3 (Saadaldin et al146) describes the 
synthesis of precursor glasses, characterization of their crystallization kinetics, and 
synthesis of three wollastonite GCs from glass powders that had variable weight 
percentages of their chemical constituents. The mechanical properties, machinability and 
chemical durability of the wollastonite GCs are presented. Fracture toughness values of 
the wollastonite GCs before and after chemical degradation testing is reported. The GC 
that showed the best mechanical properties and excellent chemical durability was selected 
for the following study. Chapter 4 (Saadaldin et al147) describes evaluation of the 
bioactivity in SBF and biocompatibility (including osteoblast attachment, focal adhesion 
formation, proliferation and ALP activity) of the wollastonite GC, which was synthesized 
as described in Chapter 3. Chapter 5 includes the general discussion, overall conclusions, 
significances, limitations of the study and a brief description of potential areas for future 
studies. 
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CHAPTER 2 
SYNTHESIS OF BIOACTIVE AND MACHINABLE MISERITE 
GLASS-CERAMICS FOR DENTAL IMPLANT APPLICATIONS 
This chapter describes a novel approach for the synthesis of miserite GC with 
mechanical, physical and biological properties required for non-metallic dental implant 
applications. The contents of this chapter have been reproduced (with modifications) 
from: Saadaldin, SA; Dixon, SJ; Costa, DO and Rizkalla, AS. Synthesis of bioactive and 
machinable miserite glass-ceramics for dental implants applications. Dental Materials. 
2013 Jun; 29(6): 645-655. doi: 10.1016/j.dental.2013.03.013, with permission from 
Elsevier (Appendix A).  
2.1 INTRODUCTION   
Dental implantology has become a predictable treatment for patients with missing teeth. 
Titanium (Ti) is the material most widely used for dental implants due to its superior 
mechanical properties, biocompatibility and resistance to corrosion. However, a long term 
clinical study revealed biological and technical complications with Ti dental implants.1 
Hypersensitivity and allergic reactions to Ti dental implants occur, although these 
reactions are under-reported, and the etiological factors of implant failure are poorly 
understood.2-4 In addition, the esthetic outcomes of Ti dental implants can be 
compromised in cases of gingival tissue recession, especially when replacing anterior 
teeth.5 
Ceramics were introduced as potential materials for non-metallic dental implants. Among 
a variety of choices, the material currently used is yttria-stabilized tetragonal zirconia (Y-
TZP).6 Advantages of zirconia include tooth-like color, good mechanical properties, 
biocompatibility, low affinity for plaque, and osseointegration comparable with Ti dental 
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implants.5,7 However, zirconia undergoes accelerated aging under stress in the presence of 
moisture, leading to surface deterioration, nucleation and propagation of microcracks that 
can result in spontaneous catastrophic failure.8-10 
Bioactivity is defined as the ability of biomaterials to promote the formation of a 
crystalline HA layer from physiological fluid.11 In implantology, there is considerable 
interest in bioactive materials to establish strong chemical bonding between the implant 
and bone, as well as to accelerate implant anchorage by inducing an HA layer on the 
implant surface.12,13 Ti and zirconia are considered bioinert; therefore, to improve their 
osseointegration, different bioactive coatings such as plasma-sprayed HA have been 
developed.5,14 However, such coatings do not degrade uniformly, giving rise to weak 
points at the bone-coating-implant interfaces.11 
GCs are produced by controlled nucleation and crystallization of glasses, and their 
properties can be tailored for specific applications.15 Glass crystallization can be 
determined by differential thermal analysis (DTA), which is thermoanalytic technique 
that is universally accepted as a rapid and convenient mean for determining the nucleation 
and crystallization temperature of glasses.16 Experimental glass and an inert reference (α-
Al2O3) are made to undergo identical thermal cycles, the temperature differences between 
sample and the reference are used to get DTA curve that provide data on glass transition, 
crystallization and melting.17 The appearance of endothermic and exothermic peaks in the 
DTA curve corresponds to nucleation and crystallization temperature, respectively.18  
There is great interest in GCs that possess appropriate physical, mechanical and 
biological properties for biomedical applications. These properties can be improved and 
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modified by varying the base glass composition or heat treatment conditions.15 Currently, 
several bioactive GCs are used for orthopaedic applications, including vertebral 
prostheses, middle ear devices and bone defect fillers.15 Miserite is a triclinic potassium 
calcium silicate mineral [KCa5(Si2O7)(Si6O15)(OH)F], which has a lath or rod-like crystal 
shape.19 Miserite was introduced in 1999 as the predominant crystal phase in multi-phase 
GCs that showed high bending strength (175 MPa) and high fracture toughness 
(>3.5 MPa·m0.5).20 It is anticipated that miserite GC is biocompatible and bioactive; 
however, it has not been evaluated previously as a material for dental implant 
applications.20  
Machinable biomaterials allow dentists to design and fabricate customized dental 
restorations with a high level of accuracy and precision through CAD-CAM technology.21 
Introducing CAD-CAM technology in dental implantology offers dental clinicians a 
variety of treatment plans, with customized implants for each individual patient. The 
objective of this study was to synthesize and characterize bioactive and machinable 
miserite GCs, with physical, mechanical and biological properties appropriate for dental 
implant materials. 
2.2 MATERIALS AND METHODS: 
2.2.1 Glass Synthesis 
Preliminary unpublished work conducted in our laboratory involved the synthesis of a 
range of multicomponent glass compositions in the system (SiO2-Al2O3-CaO-CaF2-K2O-
B2O3-La2O3) by wet chemical synthesis using sol-gel chemistry followed by spray-
drying, calcinations and melting. The glass composition (wt %) that was selected for the 
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present study was 57.8 SiO2, 0.5 Al2O3, 18.4 CaO, 12.6 CaF2, 6.8 K2O, 1.0 B2O3 and 
2.9 La2O3. The rationale for using this composition was based on getting transparent 
glass, lowering the glass melting in addition to optimizing its mechanical properties. We 
made sure that the reagents used were of high purity and soluble in water to insure the 
homogeneity of the final product. The glass was synthesized through the following four 
steps: 
1) Hydrolysis and polycondensation of metal alkoxides by mixing appropriate amounts of 
Si(C2H5O)4, Al(NO3)39H2O, Ca(NO3)24H2O, CaF2, KNO3, H3BO3 and La(NO3)36H2O in 
aqueous solution using excess deionized water.  
2) Spray-drying with feed flow rate of 10 ml/min, inlet air temperature of 160 °C and 
outlet air temperature of 80 °C using a 190 mini spray-dryer (BÜCHI, Switzerland), 
yielding a spray-dried powder.  
3) Calcination of the powder by heating incrementally at 200 °C, 500 °C and 700 °C for 
2 h each in a Ney 650 vacuum oven (Ney-Barkmeyer, USA).  
4) Melting of the calcined powder in an uncovered platinum crucible at 1150 °C for 3 h 
and 1250 °C for 1 h in a high temperature furnace (Thermolyne Corporation, USA), 
followed by quenching in iced water to obtain transparent glass frits. 
2.2.2 Crystallization Kinetics 
Transition and crystallization temperatures of experimental glasses were determined by 
DTA using a SDT Q600 V20.5 Build 15 system (TA Instruments, USA) under air 
atmosphere at five different heating rates (10-50 °C/min), starting from room temperature 
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up to 1200 °C. The average sample weight was 20 mg and an equivalent weight of α-
Al2O3 was used as a reference. The activation energy (∆E) was calculated from the plot of 
ln ((Tp)2/Ø) vs 1000/Tp using the Kissinger equation,17 where Tp is the exothermic peak as 
determined from the DTA spectra and Ø is the heating rate (°C/s). The Avrami exponent 
(nA) was determined from the DTA exothermic peak using the Augis-Bennett equation16  
Avrami Exponent (nA)= ……………………………………………(Eq 2-1) 
where ∆T is the full width at the half maximum of the exothermic peak determined at 
heating rate 20 °C/min, R is the universal gas constant (8.314 J/mol·K) and ∆E (kJ/mol) is 
the activation energy of crystallization. 
2.2.3 Preparation of Glass-Ceramics  
Glass powders were ground using a planetary ball mill, Pulverisette 7 (Laval Lab, USA) 
and mixed with 4% polyethylene glycol as a binder. Cylindrical ingots (6 mm X 10 mm) 
and disk specimens (12 mm X 1 mm) of the glass powder were produced by cold pressing 
by means of a Carver laboratory cold press (Carver, USA) in stainless steel dies at 
40 MPa. 
To study the effect of heat treatment on mechanical properties and crystallization of GCs, 
four different heating schedules were performed to produce four different GCs from the 
precursor glass (GC1, GC2, Gc3 and GC4). Pressed glass specimens were heated to 
600 °C (glass transition temperature Tg) for 1 h, after which the temperature was 
subsequently increased to the crystallization temperatures determined from the DTA 
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exothermic peaks. The firing shrinkage of the resultant GCs was calculated from the 
values of the specimen diameters before and after sintering.  
2.2.4 X-Ray Diffraction (XRD) 
Crystalline phases within the GCs were studied by XRD using a Rotaflex RTP 300 RC 
(Rigaku Corp., Japan) operating on CoKα radiation at 45 kV and 160 mA. Spectra were 
collected in the 2θ range between 2 and 82°, with 0.05° step and 10°/min scan speed. 2θ 
for equivalent CuKα radiation was calculated using Bragg’s Law.22 
2.2.5 Microstructure 
The fracture surfaces of the GCs were examined using LEO 1540XB FIB/SEM (Zeiss, 
Germany) equipped with an energy dispersive X-ray spectroscopy (EDX) system. Prior to 
SEM analysis, samples were mounted on aluminum stubs and then coated with 3 nm 
osmium metal (Filgen OPC 80T). 
2.2.6 Dynamic Young’s Modulus of the Glass and GCs 
Poisson’s ratio and dynamic Young’s moduli of the glass and GCs were measured using a 
pulsed ultrasonic method. Lithium niobate crystals were used for transmitting and 
receiving signals, which were generated at 10 MHz resonant frequencies. The elastic 
parameters were calculated using the following equations.23 
Poisson’s ratio (υ)=  …………………………………………...(Eq1-2) 
Young’s Modulus (E) =  ……….…………………………….(Eq1-3) 
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where VL and VS are the longitudinal and shear wave velocities, respectively, which were 
calculated from the thickness of each specimen and the travelling time of the waves 
across the specimen as determined using a V-66S oscilloscope at 60 MHz (Hitachi, 
Japan). The density of each specimen (ρ) was determined using the Archimedes method 
in distilled water at room temperature.  
2.2.7 True Hardness 
The true hardness (Ho) of the glass and GCs specimens was determined using a Buehler 
Micromet 5114 Knoop micro hardness indenter (Buehler, USA). Glass and GCs 
specimens were embedded in resin and polished. A series of Knoop indentations were 
performed on each specimen at six different loads (0.49-9.9 N). The average diagonal 
lengths of the Knoop indentations were measured using Buehler OmniMet MHT 7.2 
Rev.2 optical microscope equipped with a digital camera and computer software 
(Buehler, USA). Indentation lengths were plotted vs the square root of the different load 
values, and Ho was calculated from the slope of the linear regression line (S) using the 
following equation.24 
True hardness (Ho) = ………………………………………………………………………..…… (Eq2-4) 
2.2.8 Fracture Toughness 
The facture toughness (KIC) of the glass and GCs were assessed using Micromet 5114 
Vickers micro hardness indenter (Buehler, USA). The diagonals of the Vickers 
indentation and the crack lengths were measured to calculate the KIC using the Lankford 
equation.25 
214229 S
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Fracture Toughness (KIC) =  ………………(Eq2-5) 
where Ho is the true hardness (GPa), a is half the diagonal of the Vickers indentation 
(µm), E is the dynamic Young’s modulus (GPa), and c is the crack length from the corner 
of the Vickers indentation (µm). The average KIC was calculated from 15 indentations 
performed on each specimen at a load of 9.8 N.  
2.2.9 Machinability 
The machinability of the GCs was assessed qualitatively by drilling holes and preparing 
the samples by cutting shoulder finish lines, bevels and grooves with different depths. 
Quantitative evaluation of the machinability of the GCs was performed by calculating the 
brittleness index, which is the ratio of hardness to fracture toughness.26 
Brittle Index (BI) = …………………………………………………..…(Eq2-6) 
2.2.10 Bioactivity 
The GC that exhibited the best mechanical properties was selected for bioactivity and cell 
compatibility studies. The ability of GC4 to induce formation of an apatite surface layer 
was evaluated by means of soaking in SBF in vitro.27 Specimens were immersed in SBF 
at 37 °C for 1, 2 and 4 weeks. At predetermined times, specimens were thoroughly rinsed 
and dried. The surface layer formed on each specimen was assessed using SEM, EDX and 
XRD.  
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2.2.11 Cell Number and Morphology 
MC3T3-E1 Subclone 4 (ATCC/CRL-2593, USA) osteoblast-like cells are a clonal non-
transformed cell line originally established from newborn mouse calvariae.28 These cells 
exhibit properties of osteoblasts, including elevation of cyclic AMP in response to 
parathyroid hormone, expression of transcripts for Runx2, bone sialoprotein and 
osteocalcin, and formation of bone-like matrix in vitro and in vivo.29 GC4 discs were 
compared to sandblasted and acid-etched titanium (STi) as a positive control. STi discs 
were generously supplied by Institut Straumann AG. GC4 (12 mm X 1 mm) and STi 
(15 mm X 1 mm) discs were cleaned and sterilized using an argon-based plasma cleaner 
PDC-32G (Harrick plasma, USA), placed in 24-well plates, and seeded with 5,000 cells 
per well. Culture medium consisted of α-minimum essential medium (α-MEM, 
Invitrogen, CA) buffered with HCO3-, and supplemented with 10% heat-inactivated fetal 
bovine serum (FBS) and 1% antibiotic solution (10,000 U/ml penicillin, 10,000 µg/ml 
streptomycin, and 25 µg/ml amphotericin B). After 6, 24 and 72 h incubation at 37 °C in 
a humidified atmosphere of 5% CO2 in air, cells were fixed with 4% paraformaldehyde. 
After fixation, cells were stained for filamentous actin (F-actin) using rhodamine 
phalloidin (1:100 in 3% BSA in PBS). Images were obtained using an Axiovert inverted 
fluorescence microscope (Carl Zeiss, Germany). Samples were mounted on glass 
coverslips using Vectashield (Vector Laboratories, CA) with 4', 6-diamidino-2-
phenylindole dihydrochloride (DAPI) for visualization of cell nuclei. The number of cells 
present at 6, 24 and 72 h was calculated from 10 randomly selected fields from each 
specimen. 
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2.2.12 Cell Proliferation Assay 
MC3T3-E1 cells were seeded at 5,000 cells per well on GC4 and STi discs and the 
culture medium was refreshed every other day. At 1, 3, 5 and 7 days, culture medium was 
removed and specimens with cells were frozen at -80 °C. MC3T3-E1 cell numbers were 
determined using CyQuant® cell proliferation assay kit (Invitrogen, USA). All specimens 
were thawed at room temperature, then 400 µL of the CyQuant® GR dye/cell lysis buffer 
was added to each sample surface. A fluorescence microplate reader (Tecan Safire, USA) 
was used to measure fluorescence intensity of the dye/buffer at emission of 520 nm and 
excitation of 480 nm. Fluorescence intensity was converted to cell number using a 
standard curve. Cell numbers were normalized to account for the difference in surface 
area between the GC4 and STi specimens.  
2.2.13 Statistical Analyses 
Differences between two groups were evaluated by t tests. Differences among three or 
more groups were evaluated by one-way analysis of variance (ANOVA) followed by 
Tukey’s multiple comparisons test. Differences were accepted as statistically significant 
at p<0.05; N indicates the number of independent experiments. 
2.3 RESULTS  
2.3.1 Differential Thermal Analysis (DTA) of Glass 
The crystallization kinetics of the experimental glass that was synthesized by wet 
chemical methods was determined by DTA. When the glass was heated, the DTA 
spectrum displayed three important features (Figure 2-1A). The first shoulder 
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endothermic peak corresponds to the glass transition temperature (Tg). The exothermic 
peaks (Tp1 and Tp2) demonstrate the crystallization temperatures of the glass. The second 
endothermic peak reveals the liquidus temperature (Te), which resulted from 
decomposition and dissolution of the crystalline phases. 
DTA was performed at five different heating rates (Table 2-1). Tg, Tp1, Tp2 and Te 
increased as the heating rate was increased. The Avrami exponent (nA) at the 
crystallization temperature was calculated from the full width at the half maximum of the 
exothermic peak(s) at 20 °C/min (Figure 2-1B). The nA values for the two crystallization 
temperatures are displayed in Table 2-2. The nA value for TP1 was 1.1 (consistent with 
surface crystallization), whereas the nA value for Tp2 was 2.8 (consistent with bulk 
crystallization).18 The activation energies of crystallization of the two exothermic peaks 
(Table 2-2) were calculated from the slope of the regression lines (ln ((Tp) 2/Ø) vs. 
1000/Tp) displayed in Figure 2-1C. Based on the DTA data, four heating schedules were 
selected for crystallization of four different GCs (Table 2-3). 
2.3.2 XRD Analysis of Glass and GCs 
XRD spectrum of the as-quenched glass confirmed its amorphous nature as revealed by 
the shallow hump at 2θ = 25°– 35° (Figure 2-2A). The glass specimens were sintered 
using four heating schedules (Table 2-3), yielding GC1, GC2, GC3 and GC4. XRD of 
GC1 revealed crystalline phases consisting predominately of calcium fluoride silicate 
Ca2SiO2F2 (ICDD-PDF # 35-2), accompanied by xonotolite Ca6Si6O17(OH)2 (ICDD-
PDF # 29-379), hydroxyapatite Ca5(PO4)3OH (ICDD-PDF # 9-432) and miserite 
KCa5(Si2O7)(Si6O15)(OH)F (ICDD-PDF # 22-806) (Figure 2-2B).30 GC2 exhibited 
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greater peak intensity at 2θ = 28.1°, indicative of an increase in miserite content 
(Figure 2-2C). GC3 displayed an XRD spectrum (Figure 2-2D) similar to that of GC2. 
Finally, the GC4 spectrum showed a predominantly miserite crystalline phase, 
accompanied by other minor phases (Figure 2-2E). The XRD spectra indicated the 
successful synthesis of various GCs, consisting of variable amounts of calcium fluoride 
silicate, xonotolite, hydroxyapatite and miserite. 
2.3.3 Microstructure of Glass and GCs 
SEM of fracture surfaces of glass did not reveal any indication of crystalline phases 
(Figure 2-3A). Fracture surfaces of the GCs varied greatly with differences in the heating 
schedule (Figure 2-3B-E). GC1 showed a mixture of spherulitic and acicular crystals 
(Figure 2-3B). GC2 and GC3 showed predominant long laths with spherulitic crystals 
(Figure 2-3C,D). In contrast, the principal microstructural features of GC4 were long 
laths and logs with different aspect ratios (Figure 2-3E), consistent with the miserite 
crystalline phase. 
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Figure 2-1: Differential thermal analysis (DTA) of the experimental glass powder. (A) 
Representative data from DTA of the experimental glass powder at 20°C/ min heating 
rate shows the glass transition (Tg), first and second exothermic peaks (Tp1, Tp2) and 
liquidus temperatures (Te). (B) Expanded exothermic peak for the glass at 20 °C/min 
heating rate. ∆TFWHM is the full width at half maximum of the exothermic peak. (C) Typical 
DTA plots of ln(Tp)2/Ø vs. 1000/Tp for the first and second peaks of the glass at heating 
rates ranging between 10-50 °C/min, r is the correlation coefficient determined from 
linear regression. Data are representative of 3 independent determinations. 
 
Table 2-1: Differential thermal analysis (DTA) data for experimental glass fired from RT 
to 1200 °C at five different heating rates ranging between 10 -50 °C/min. Data are means 
(SD), n = 3. 
Heating rate 
(°C/min) 
Tg (°C) Tp1 (°C) Tp2 (°C) Te (°C) 
10 601 (2.7) 821 (1.9) 958 (2.1) 1073 (3.1) 
20 603 (2.2) 841 (1.7) 983 (12.7) 1075 (1.4) 
30 606 (3.4) 854 (1.3) 1024 (6.1) 1080 (25.7) 
40 613 (2.2) 859 (1.6) 1031 (3.4) 1087 (28.8) 
50 615 (2.5) 866 (1.4) 1038 (2.9) 1090 (4.5) 
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Table 2-2: Avrami exponents and activation energies of the glass crystallization. 
Calculated from the first and second DTA exothermic peaks. Data are means (SD), 
n = 3. 
 
 Tp1  Tp2  
Avrami Exponent (nA) 1.1 (0.1) 2.8 (0.3) 
Activation Energy (∆E, kJ/mole) 354 (24) 217 (6) 
 
Table 2-3: Heat treatment schedules for experimental glass-ceramics. 
Heating 
Schedules 
Samples Heating rate* 
(°C/min) 
Heat Treatment 
Temperature (°C) Holding time* (h) 
1 GC1 20 600 
850 
1 
4 
2 GC2 20 600 
850 
1000 
1 
4 
2 
3 GC3 5 600 
850 
1 
4 
4 GC4 5 600 
850 
1000 
1 
4 
2 
*Heating rate and holding time are experimental and not based on DTA data 
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Figure 2-2: X-ray diffraction (XRD) of the as-quenched glass (A), GC1 (B), GC2(C), GC3 
(D) and GC4 (E). GCs were treated at different heating rates, temperatures and holding 
times, as specified in Table 3 
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Figure 2-3: (A-E) Microstructure of fractured surfaces of as-quenched glass and GCs as 
determined by scanning electron microscopy (SEM). (A) Amorphous glass. (B) 
Microstructure of GC1 shows mixture of spherulitic and acicular crystals that represent 
calcium fluoride silicate crystalline phase and other secondary crystalline phases. (C, D) 
Microstructures of GC2 and GC3 reveal mixture of spherulitic and dominant long laths 
crystals. (E) Microstructure of GC4 showing the principal phase of randomly oriented 
long laths and logs with different aspect ratio that represent miserite crystalline phase. 
(F) Macroscopic image of machined GC4 specimens: (i) drilled hole and grooves cut 
along specimen perimeter, and (ii) shoulder preparation free of cracking and chipping. 
Images are representative of 3 independent preparations. 
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2.3.4 Physical and Mechanical Properties  
The firing shrinkage of the GCs ranged between 14-18 %. The mean density and 
Poisson’s ratio values for the as quenched glass and GCs ranged between 2666-
2868 kg/m3 and 0.17-0.22, respectively (Table 2-4). The Young’s moduli (E values) for 
the GC2, GC3 and GC4 were significantly higher than the as quenched glass (p<0.05). 
These values ranged between 90-96 GPa, and GC4 exhibited the greatest E. The true 
hardness (Ho) and fracture toughness (KIC) values of the GCs were significantly increased 
by heat treatment of the glass. These values ranged between 4.33-5.27 GPa, and 3.81-
4.77 MPa·m0.5, respectively. Additionally, the brittleness index (BI) values for the GCs 
were significantly lower than that of the glass (p<0.05). GC4 exhibited the lowest value at 
1.10 µm-0.5 (Table 2-4). Moreover, GC4 could be prepared smoothly and it did not exhibit 
any surface cracking or chipping as a result of machining (Figure 2-3F). GC4 was 
selected for further studies to assess its bioactivity in SBF and biocompatibility with 
cultured cells, because of its excellent mechanical properties and machinability and it 
exhibited miserite as the main crystalline phase compared to other GCs. 
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Table 2-4: Physical and mechanical properties of experimental glass and glass-
ceramics. Data are means (SD), n = 3. Different superscript letters denote that values 
are significantly different (p<0.05) based on ANOVA and Tukey’s multiple comparisons 
test. 
Properties Glass GC1 GC2 GC3 GC4 
Density (ρ, kg/m3) 2706 (3) 2666 (18) 2868 (12) 2818 (16) 2859 (37) 
Poisson’s ratio (ʋ) 0.22 (0.30) 0.20 (0.02) 0.20 (0.03) 0.18 (0.02) 0.17 (0.01) 
Young’s modulus 
(E, GPa) 
78.1 (0.5)a 80.1 (4.2)a 94.9 (2.4)b 89.8 (0.5)b 95.9 (2.5)b 
 
True hardness 
(Ho, GPa) 
3.83 (0.09)a 4.33 (0.12)b 5.20 (0.42)c 4.84 (0.24)c 5.27 (0.26)c 
 
Fracture toughness 
(KIC, MPa·m0.5) 
 
1.46 (0.14)a 
 
3.81 (0.55)b 
 
4.53 (0.60)c 
 
3.90 (0.22)b 
 
4.77 (0.27)c 
 
Brittleness index 
(BI, µm-0.5) 
 
2.62 (0.05)a 
 
1.14 (0.13)b 
 
1.14 (0.18)b 
 
1.24 (0.07)b 
 
1.10 (0.05)b 
 
2.3.5 Bioactivity of GC4 
The SEM and EDX analyses of the GC4 specimens before and after soaking in SBF 
demonstrated successful deposition of a calcium phosphate surface layer (Figure 2-4A, 
B). As early as 1 week after immersion in SBF, the surface of the GC4 was covered with 
a distinct coating (Figure 2-4Aii). Immersion of GC4 specimens for 4 weeks resulted in 
the formation of a uniform surface layer having morphology similar to that of biomimetic 
HA (Figure 2-4Aiv). EDX elemental analysis revealed an increase in the intensity of the 
peaks attributed to Ca and P and gradual diminution of the Si peak after soaking in SBF 
for increasing times (Figure 2-4B and Table 2-5). The calcium to phosphorous ratio 
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(Ca/P) of the surfaces was in the range of 1.50-1.64, which is similar to bone-like apatite 
(Ca/P ≈ 1.50) and approaching that of stoichiometric HA (Ca/P = 1.67).31 
XRD spectra of the GC4 samples after immersion in SBF confirmed the formation of an 
HA layer on the GC surfaces (Figure 2-4Cii-iv). The results showed attenuation of the 
XRD peaks associated with GC4 after 1 and 2 weeks soaking in SBF, and the appearance 
of peaks at 2θ = 26° and 32°, indicative of a poorly crystalline HA (ICDD-PDF # 09-
432). Moreover, after 4 weeks soaking in SBF, only peaks ascribed to HA were visible, 
consistent with the formation of a thick apatite layer. Taken together, the SEM, EDX, and 
XRD results confirmed the deposition of an HA surface layer after immersion of GC4 in 
SBF, indicating its bioactivity. 
 
Table 2-5: Energy dispersive X-ray spectroscopy (EDX) analysis of GC4 and molar Ca/P 
ratio for different soaking times in SBF. Data are means (SD), n = 3. 
Soaking time 
(Week) 
Si 
Atomic % 
Ca 
Atomic % 
P 
Atomic % 
Molar 
Ca/P ratio 
0 21.38 (0.47) 17.19 (0.52)  0.12 (0.08) ------------ 
1 0.83 (0.25) 14.36 (0.21)  9.15 (0.07)  1.57 (0.01) 
2 1.04 (0.33) 14.61 (0.33)  9.73 (0.14)  1.50 (0.03) 
4 ----------- 18.68 (0.65)  11.37 (0.28)  1.64 (0.02) 
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Figure 2-4: Bioactivity of GC4. (A) SEM surface morphologies, (B) EDX spectra and (C) 
XRD of GC4 before (i) or after soaking in SBF for 1 (ii), 2 (iii) or 4 (iv) weeks. (A) SEM 
micrographs illustrate the surface morphology of the GC4 before soaking in SBF and the 
formation of HA layer on the GC4 surfaces at low and high magnifications at different 
times. (B) EDX spectra show the Si, Ca and P peaks before and after soaking in SBF. 
(C) XRD confirmed the gradual formation of HA surface layer on the GC4 surfaces at 
different soaking times in SBF. At 4 weeks, the XRD showed the spectrum of HA only 
(PDF#19-272), indicating that GC4 is totally covered with HA layer (Civ).  
 
2.3.6 Cell Morphology and Number on GC4 and Titanium 
MC3T3-E1 osteoblast-like cells were cultured for 6, 24 and 72 h on GC4 and titanium 
surfaces. Sand-blasted and acid-etched titanium (STi) was used as a positive control as it 
is a biocompatible material approved for clinical implant applications.32 Fluorescence 
images at different incubation times showed that cells attached to both GC4 and STi, but 
spreading was markedly greater on GC4 at 6 h (Figure 2-5A-D). Cells on GC4 surfaces 
were flattened and well spread with polygonal shapes. Higher magnification images 
revealed the formation of stress fibers and few filopodia. In contrast, at 6 h the cells on 
STi were spindle-shaped with distinct filopodia along the periphery of cells and longer 
cytoplasmic extensions. There was no significant difference between the number of cells 
present on GC4 and STi after 6 and 24 h incubation. However, by 72 h, there was a 
significant increase in cell numbers on both GC4 and STi (Figure 2-5M, p<0.05), 
consistent with proliferation of MC3T3-E1 cells on both surfaces. Also we note, there 
were significantly greater cell numbers on GC4 than on STi at 72 h (Figure 2-5M, 
p<0.05).  
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Figure 2-5: Osteoblast attachment, spreading and morphology on GC4 and titanium. 
MC3T3-E1 osteoblast-like cells were cultured for 6, 24 and 72 h on GC4 and titanium 
(STi, control) substrata. Cells were then fixed and stained for filamentous actin (F-actin, 
red) and nuclei (blue). (A-L) Images were obtained by fluorescence microscopy at low 
and high magnifications. (M) Cell number was quantified by counting cells on GC4 and 
STi discs after 6, 24 and 72 h. Cells were counted on 10 randomized fields on each 
sample. Cell count data are means (SD) based on 3 independent experiments each 
performed on triplicate samples. There was no significant difference between osteoblast 
attachment to GC4 and titanium at 6 and 24 h. On the other hand, at 72 h, the cell 
number was significantly greater on GC4 compared to STi (p<0.05) based on ANOVA 
and Tukey’s multiple comparison tests. 
 
 
 
 
 
 
 
Figure 2-6: Osteoblast proliferation on GC4 (A) and titanium (B). Cell numbers were 
quantified after 1-7 days incubation using the CyQUANT® proliferation assay. Data are 
means (SD) based on 3 independent experiments each performed on triplicate samples. 
Because of different surface areas of GC4 and STi (113 mm2 and 177 mm2, 
respectively), cell numbers on GC4 were normalized to the cell numbers on STi. 
Different lowercase letters denote significantly differences (p<0.05) based on ANOVA 
and Tukey’s multiple comparisons tests.  
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2.3.7 Cell Proliferation on GC4 and Titanium 
To further investigate the ability of these surfaces to support cell proliferation, MC3T3-
E1 cells were cultured for 1 to 7 days on GC4 and STi. Cell numbers were quantified 
using the CyQuant® cell proliferation assay (Figure 2-6). Both GC4 and titanium 
supported cell proliferation, with significant increases at days 5 and 7 on both substrata 
(p<0.05). Taken together, results of the cell studies established that GC4 is at least 
comparable to titanium in terms of its ability to support the attachment, spreading and 
proliferation of osteoblast-like cells.  
2.4 DISCUSSION 
GCs are typically produced by melting glasses at high temperature (~1500 °C), which 
results in significant fluorine loss and adversely influences the glass mechanical 
properties.15 In the present study, the combination of wet-chemistry and spray-drying 
resulted in a more homogeneous glass with lower melting point (1250 °C) compared to 
similar compositions prepared by conventional methods.20 Maintaining the fluorine 
content in the glass improves its sinterability and mechanical properties.33,34  
The GCs synthesized in this study displayed good sintering characteristics by maintaining 
the initial sample shape and integrity, features which are attributable in part to the 
homogeneity of the precursor glass produced by wet chemistry.35 Additionally, the glass 
powder was calcined at low temperature (200-700 °C) to remove adsorbed moisture and 
impurities remaining from the synthesis stage.11 
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Biomaterials are considered bioactive when a strong interfacial bond forms between the 
implant and the surrounding bone tissue; through the formation of a carbonated HA layer 
at the interface.13 This HA layer is similar in composition and structure to the apatite in 
bone.36 The presence of an HA layer prevents fibrous tissue formation around the implant 
that could hinder bone integration. In addition, the interfacial bond improves the load 
distribution between the biomaterial and the surrounding bone and, as a result, diminishes 
stress shielding.37 The GCs synthesized in this study are bioactive as evidenced by the 
complete coverage of the GC4 surfaces with HA after 4 weeks of soaking in SBF. The 
molar Ca/P ratio of the apatite surface layer ranged between 1.57 and 1.64, in good 
agreement with the characteristics of biological HA.31 
To our knowledge, there are currently no bioactive machinable non-metallic materials 
used for dental implants. Therefore, it is relevant to compare characteristics of the 
experimental miserite GC described in the present study to those of titanium (used 
extensively for dental implants) and zirconia (recently introduced to the oral implantology 
field.1,5 Both titanium and zirconia lack the bioactivity of miserite 
The high stiffness of titanium dental implants (105-116 GPa) and dental zirconia 
(~200 GPa) do not match that of human bone (4-20 GPa).6,38 This mismatch gives rise to 
stress shielding,39 where the bone is inadequately loaded leading to bone resorption and 
subsequent implant failure.37,39 Although, the stiffness of the miserite GCs developed in 
the present study are still high (80-96 GPa), they are less than that of Ti and zirconia, and 
could potentially reduce stress shielding. 
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Currently, zirconia dental implants have poor machinability as they undergo accelerated 
aging due to development of micro cracks.8-10 Moreover, milling and machining of 
zirconia implants negatively impact the final implant fracture strength.9,40 The good 
machinability of the experimental GCs is attributed to the randomly oriented, interlocking 
lath crystals.34  
When miserite GC is machined, micro cracks developed at the glass/crystal interfaces 
will be hindered by the interlocking lath crystals, which act as a barrier against 
catastrophic crack propagation.21 BI has been proposed as a quantitative measure of 
machinability, where ceramics with a BI value less than 4.3 µm-0.5 are considered 
machinable.26 This was the case for GC4, with a BI of only 1.1 µm-0.5. Moreover, GC4 
could be milled into different shapes without cracking, indicating its potential for the 
production of dental implants by CAD-CAM technology. 
Attachment of cells of the osteoblast lineage to the biomaterial surface is an initial step 
towards the formation of new bone tissue surrounding the implant.32 The osteoblast-like 
cell line, MC3T3-E1, used in the present study has been widely used to assess the 
biocompatibility of Ti dental implant materials.32 Osteoblast-like cells attached, spread 
and proliferated on GC4, which indicates that GC4 is biocompatible. Interestingly, cell 
morphology differed on the relatively smooth surface of GC4 and the rougher surface of 
STi, likely reflecting differences in surface chemistry and topography. These results are in 
agreement with previous studies, which demonstrated that osteoblasts attach, spread and 
proliferate differently on smooth surfaces as compared to rough surfaces.32,41 At 24 and 
72 h, cells exhibited specific morphology and actin stress fibers were clearly visible. 
Moreover, both the GC4 and STi surfaces supported cell proliferation.  
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When the synthesized transparent glass was heat treated and crystallized to form GCs, it 
became white opaque. It likely lost transparency as a result of random light scattering and 
the difference in refractive index between the crystal and the parent glass.42 Regardless, 
GC4 is esthetically acceptable as a dental implant when compared with Ti dental implants 
that may show a grayish line at the gingival margin. The metal-free GC dental implant 
preserves the natural color of the soft tissue surrounding the dental implant and improves 
the esthetic outcome of treatment. 
Preliminary studies were performed on these GC, assessing their chemical durability in 
acetic acid and degradation in tris-buffered solution (Appendix B). Results of these initial 
studies suggested that miserite GC was not sufficiently stable to meet the requirements of 
dental restorations exposed to the oral environment or implanted in bone. These data 
motivated us to modify the GC composition, keeping the favorable mechanical, physical 
and biological properties, while improving chemical durability. Synthesis and 
characterization of the resulting wollastonite glass-ceramics are described in Chapters 3 
and 4. 
2.5 CONCLUSIONS 
Glass ceramic containing miserite [KCa5(Si2O7)(Si6O15)(OH)F] as the dominant phase 
was prepared by wet chemistry, spray-drying and sintering (bulk crystallization). The 
microstructure of GC4 was primarily interlocked log and lath crystals, which contributed 
to high KIC (4.77 MPa·m0.5), as well as excellent machinability. In vitro tests showed that 
miserite GC is bioactive and supports the attachment and proliferation of osteoblast-like 
cells comparable to clinically proven titanium surfaces. 
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CHAPTER 3 
SYNTHESIS AND CHARACTERIZATION OF WOLLASTONITE 
GLASS-CERAMICS FOR DENTAL IMPLANT APPLICATIONS 
This chapter describes a novel approach for the synthesis of GCs with mechanical, 
physical and chemical properties required for non-metallic dental implant applications. 
The contents of this chapter have been reproduced (with modifications of the glasses and 
glass-ceramics nomenclature) from a manuscript that has been accepted for publication 
in Dental Materials (Saadaldin et al, Dental Materials, DEMA-D-13-00398R1). 
3.1 INTRODUCTION  
Glass-ceramics are polycrystalline materials with an inorganic-inorganic microstructure 
that were prepared from base glass by controlled crystallization. This was achieved by 
subjecting glasses to regulated heat treatment, which resulted in the nucleation and 
growth of one or more crystal phases within the glass. GCs have diverse physical, 
chemical, mechanical, optical and biological properties that can be modified with glass 
composition and heat treatment conditions.1 As a consequence of the continuous need of 
the general public as well as the dental professionals to eliminate dental metal-based 
products, there is a trend towards GCs and ceramic-based materials in the biomedical 
field.2 Yttrium-stabilized tetragonal zirconia polycrystalline has been used extensively as 
a material of choice for ball heads in total hip replacement since 1980s, and it became 
commercially available as non-metallic dental implants in 2000s, owing to its strength, 
fracture resistance and appropriate optical properties.3 However, zirconia undergoes aging 
through low-temperature degradation phenomenon that is moisture/water related and 
unfavorably affects its physical properties. In 2000, several hundreds of hip prosthesis 
failed over a short period of time. These failures were ascribed to an accelerated aging of 
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the zirconia femoral head in particular batches.4 Additionally, literatures showed that 
zirconia is correlated with two types of radiation impurities, alpha and gamma. Alpha 
radiation has been observed in a significant amounts and it could harm soft and hard 
tissues’ cell due to their high ionization.5,6  
The wollastonites (CaSiO3) are white glassy silicate minerals that occur as masses or 
tabular crystals of metamorphosed limestone. A silica chain GC that contains crystalline 
apatite and β-wollastonite (AW) was introduced in an MgO-CaO-SiO2-P2O5 glassy matrix 
and it showed an excellent bioactivity, biocompatibility, machinability and adequate 
mechanical properties such as Young’s modulus (117 GPa), compressive strength 
(1080 MPa), and bending strength (215 MPa).7 AW has been used for orthopedic 
applications–artificial vertebrae, intervertebral discs and iliac crest prostheses.7,8 Kokubo 
proved that the mechanical strength of the AW was significantly unaffected in simulated 
body fluid at 36.5 °C and presumed that it can withstand a bending stress of 65 MPa in 
the human body environment for over 10 years.7 Yet, the fracture toughness of the AW 
had relatively low values (2-2.5 MPa.m0.5); therefore it’s limited to non-load bearing 
applications. And we note that, a custom AW prostheses production by conventional lost 
wax casting can be difficult as a result of the surface crystallization.7 However, because 
of its excellent bioactivity, AW was used as a coating on different substrates such as 
titanium alloys9 or as a composite scaffold by incorporation of AW with other 
materials.10,11  
Fracture toughness (KIC) measures the resistance of a material to cracks propagation and 
the ability to prevent the initiation of catastrophic fracture. Indentation test has been 
considered as an accurate procedure to measure the fracture toughness for brittle 
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materials, like ceramics and GCs. The indentation method has the advantages of 
simplicity and economy; where only small specimen area is needed, hence the technique 
is suited for comparative evaluation.12 
Chemical durability affects the clinical performance of dental materials. With a wide 
range of pH and temperature, dental materials should resist chemical degradation and 
dissolution. Chemical degradation of ceramic dental materials could lead to structure’s 
weakening and surface roughness as a result of surface-ion exchange. This phenomenon 
leads to increased plaque attachment onto the biomaterials and intensify abrasion 
potential against opposing natural teeth and other restorative materials.13 
The brittle behavior of the GCs makes them sensitive to milling and machining; therefore 
the development of machinable GCs for dental implant applications is considered a 
significant progress. A machinable dental implant material can be introduced to CAD-
CAM technology and customized implants for different clinical cases can be fabricated, 
in addition to the possibility of the modification and adjusting of the implant at the time 
of surgical insertion. Machinable GCs can be used as one-piece dental implants where the 
upper part can be prepared to produce the abutment unit and get rid of multiple 
component implants i.e. fixture, screw and abutment. 
The objectives of this study were to synthesize machinable wollastonite GCs with 
mechanical properties suitable for dental implant applications, to assess their chemical 
durability using acetic acid and tris buffered solution at different time points and evaluate 
their fracture toughness following chemical degradation testing. 
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3.2 MATERIAL AND METHODS:  
3.2.1 Glass Synthesis 
Transparent glass frits were synthesized by wet chemical methods through four steps. In 
the beginning, the desired glass compositions in weight % (Table 3-1) were prepared by 
mixing batch ingredients {Si(C2H5O)4, Al(NO3)3.9H2O, Ca(NO3)2.4H2O, CaF2, KNO3, 
H3BO3, Ce(NO3)3.6H2O and Y(NO3).6H2O} in aqueous solution using excess deionized 
water, and kept stirred overnight to commence hydrolysis and polycondensation of metal 
alkoxides. This was followed by spray drying of the solutions at a feed flow rate of 
10 ml/min, inlet air temperature of 160 °C and outlet air temperature of 80 °C using a 190 
mini spray-dryer (BÜCHI, Switzerland). The spray-dried powders were calcined by 
means of a Ney 650 vacuum oven (Ney-Barkmeyer, USA) through sequential heating 
schedules at 200, 500 and 700 °C for 2 h. Finally, the calcined powders were melted in an 
uncovered platinum crucible at 1350 °C for 3 h in a high temperature furnace 
(Thermolyne Corporation, USA), followed by quenching in iced-water to obtain the glass 
frits. 
Table 3-1: Chemical composition (wt%) of the experimental glasses 
Glass 
component 
SiO2 Al2O3 CaO CaF2 K2O B2O3 P2O5 CeO2 Y2O3 
G-A 55 2 17 12 5 3 1.5 1.5 3 
G-B 59 1 15 12 5 3 2 0 3 
G-C 50 2 20 12 7 3 3 0 3 
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3.2.2 Differential Thermal Analysis 
Crystallization kinetic parameters of the glasses (G) were determined using SDT Q600 
V20.5 Build 15 (TA Instruments, USA) at different five heating rates (10-50 °C/min), 
starting from room temperature up to 1200 °C under air atmosphere; for each heating rate, 
three-independent runs were carried out (n=3). The average sample weight was 20 mg 
and an equivalent weight of α-Al2O3 was used as a reference. The activation energy (∆E) 
was calculated from the plot of ln (Tp)2/Ø vs. 1000/Tp using the Kissinger equation,14 
where Tp is the exothermic peak (°C) as determined from the DTA spectra and Ø is the 
heating rate (°C/s). The Avrami exponent (nA) was calculated using the Augis-Bennett 
equation13 from the full width at the half maximum of the exothermic peak at 20 °C/min. 
nA is related to the directionality of crystal growth, lower values (≈1) of nA reflected 
surface crystallization, whereas nA values above 1.5 indicated bulk crystallization.15  
3.2.3 Glass-Ceramics Preparation 
Glass powders were mixed with 4% polyethylene glycol as a binder and ball-milled using 
a planetary ball mill, Pulverisette 7 (Laval Lab, USA). Cylindrical ingots (6 mm x10 mm) 
and disk specimens (11 mm x 1 mm) of the glass powders were produced by cold 
pressing using a Carver laboratory cold press (Carver, USA) in stainless steel dies at 40 
MPa. Pressed glass specimens were heated for 1h at the glass transition temperature that 
was obtained from DTA spectra for the nuclei formation. Afterward the temperature was 
subsequently raised to the crystallization temperatures determined from the DTA 
exothermic peaks and held for 4 h, Table 3-2. 
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Table 3-2: Optimal heat treatment schedules for the experimental glass ceramics based 
on the DTA data. 
Samples 
Heating rate* 
(°C/min) 
Heat Treatment 
Temperature (°C) Holding time* (h) 
GC-A 20 700 
950 
1 
4 
GC-B 10 750 
1000 
1 
4 
GC-C 10 700 
950 
1 
4 
* Heating rate and holding time were experimental and not based on DTA data 
3.2.4 X-Ray Diffraction  
Crystalline phases of the GCs were analyzed by XRD using a Rotaflex RTP 300 RC 
(Rigaku Co, Japan) operating on CoKα radiation at 45 kV and 160 mA. Spectra were 
collected in the 2θ range between 2 and 82°, with 0.05° step and 10°/min scan speed. 
Bragg’s Law was used to calculate 2θ for equivalent CuKα radiation.16  
3.2.5 Microstructure 
Prior to SEM analysis, samples were mounted on aluminum stubs with silver paint and 
then coated with 3 nm osmium metal (Filgen OPC 80T). The fracture surfaces of the 
glasses and GCs were examined using LEO 1540XB FIB/SEM (Zeiss, Germany) 
equipped with an energy dispersive X-ray spectroscopy (EDX) system.  
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3.2.6 Dynamic Elastic Constants of the GCs 
The dynamic elastic properties of the synthesized GCs and yttria-stabilized zirconia (YZ) 
ceramic control (Vita Zahnfabrik, Germany) were evaluated by ultrasonic method.17 The 
density of each specimen (ρ) was determined using the Archimedes method in deionized 
water at room temperature. The dynamic elastic moduli and Poisson’s ratios (n=3) were 
calculated from the velocities of the longitudinal (VL) and shear (VS) waves which were 
determined using lithium niobate crystals that were used for transmitting and receiving 
waves at 10 MHz resonant frequencies The equations used for the calculation are reported 
elsewhere.17,18 
3.2.7 True Hardness and Fracture Toughness Evaluation  
The true hardness (Ho) and the fracture toughness (KIC) of the GCs and YZ specimens 
were determined using a Buehler Micromet 5114 Knoop and Vickers micro hardness 
indenter, (Buehler, USA), respectively. The specimens were embedded in resin and 
polished (n=3). To calculate the Ho, a series of Knoop indentations were performed on 
each specimen at six consecutive loads (0.49-9.9 N). The average diagonal lengths of the 
Knoop indentations were measured using Buehler OmniMet MH T7.2 Rev.2 optical 
microscope equipped with a digital camera and computer software (Buehler, USA). 
Indentation lengths were plotted vs. the square root of the different load values, and Ho 
was calculated from the slope of the linear regression line.19 KIC of the GCs and YZ were 
determined by measuring the diagonals of the Vickers indentation and the crack lengths 
using the Lankford equation.20 The average KIC value was calculated from 45 
indentations performed on three specimens at a load of 9.8 N.  
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3.2.8 Chemical Durability  
The ISO standard 678221 was used for assessing the chemical durability of the GCs and 
YZ. Triplicate samples were washed in distilled water in a digital ultrasonic bath (Eumax, 
China) and dried in a Temp Master “A” furnace (JELRUS, USA) at 150±5 °C for 4 h. 
The weight of the samples and the total surface area were determined to the nearest 0.1 
mg and 0.1 cm2, respectively. Specimens were soaked in 20 ml of pre-heated (80 °C) 4 % 
acetic acid (AC) solution in glass bottles. The bottles were placed in a vacuum oven 
(VWR, USA) at 80 °C for 16 h. Then the specimens were washed with distilled water in 
the ultrasonic bath, dried at 150±5 °C until a constant weight was reached. The chemical 
durability was analyzed by measuring of the specimens weight loss/ unit area (wt/A; 
µg/cm2). Later, to assess the effect of the chemical dissolution on the mechanical 
properties of the materials, the KIC were re-measured for chemically tested specimens. 
3.2.9 Degradation Testing 
The degradation testing was performed according to ISO standard 10993-14.22 The test is 
based on a buffered solution that simulates the body’s normal pH level. TRIS-HCl 
buffered solution (TBS) was prepared by dissolving tris (hydroxymethyl) aminomethane 
in water; the pH of the solution was adjusted to 7.4±0.1 with an appropriate amount of 
1 mol/L HCl acid at 37 °C. Triplicate specimens were washed in a digital ultrasonic bath 
(Eumax, China) and dried at 150±5 °C in a Temp Master “A” furnace (JELRUS, USA). 
Samples’ weights were measured, and then the specimens were soaked in freshly 
prepared TBS in polypropylene containers. The bottles were placed in a MaxQ 5000 
circular agitated controlled-temperature chamber (Thermo Scientific, USA) at 37 °C for 
different timelines (1, 3, 7, 30, 60, 90, and 120 days). At the predetermined time point the 
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specimens were washed with distilled water in the ultrasonic bath, dried to constant mass 
and weighed. The degradation of each sample was determined by calculating the 
percentage weight loss. In a similar manner as described above, the KIC for the specimens 
that were soaked for 120 days in TBS were re-measured. 
3.2.10 Machinability  
Qualitative evaluation of the machinability of the GCs was conducted through drilling 
holes, grooves, bevels as well as preparing shoulder finish lines on GCs’ ingots and discs 
of different thicknesses. Additionally, quantitative assessment was done by calculating 
brittleness index (BI), which is the ratio of the hardness to the fracture toughness. The 
lower the brittleness index, the higher the machinability.23 
3.2.11 Statistical Analyses 
One-way analysis of variance (ANOVA) followed by Tukey’s multiple comparisons test 
at a significance value of p<0.05 was used to analyze differences among groups. 
Nonlinear regression analysis was used to evaluate the degradation rates at different 
timeline. The KIC values for the chemically tested specimens at 120 days were analyzed 
with simple main effect analysis and Tukey’s multiple comparisons test, p<0.05. 
3.3 RESULTS 
The manufacturing process used in this study resulted in clear transparent amorphous 
glasses prior to any further heat treatment used to produce the final GCs. 
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3.3.1 Differential Thermal Analysis of the Glasses 
The DTA spectrum of each glass displayed the glass transition temperature (Tg) as a 
shoulder endothermic peak, the crystallization temperature of the glass (Tp) as an 
exothermic peak, and the liquidus temperature (Te), which resulted from decomposition 
and disintegration of the crystalline phases and illustrated as an endothermic peak, 
Figure 3-1A. Table 3-3 displayed the nA values and the activation energies of 
crystallization of the glasses. G-A had two exothermic peaks and the nA values for both 
peaks indicated bulk crystallization. On the other hand, G-B and G-C had one exothermic 
peak. The nA value for G-B signified surface crystallization, while that for G-C of 1.8 
denoted bulk crystallization. The activation energies of crystallization of the glasses (∆E) 
were calculated from the slope of the regression lines, ln (Tp)2/Ø vs. 1000/Tp, as 
demonstrated in Figure 3-1B. The values of the glasses’ ∆E ranged between 257 and 
360 kJ/mole, and G-B exhibited the highest value. 
Table 3-3: Avrami exponents and activation energies of the experimental glasses. Data 
are mean (SD) of three independent runs at 20°C/min. *Calculated from second 
exothermic DTA peak. 
 
 
 
 
 
 
Avrami 
Exponent (nA) 
Activation Energy     
(∆E, kJ/mole) 
G-A 1.7(0.06) 257(8) 
G-A* 1.6(0.18) 308(23) 
G-B 1.2(0.04) 360(16) 
G-C 1.8(0.04) 317(14) 
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Figure 3-1: (A): Representative DTA curve of the G-A, G-B and G-C powders at 20 °C 
heating rate. (B) Typical DTA plots of ln Tp2/Ø vs. 1000/Tp for the first peaks of the 
glasses at heating rates ranging between 10-50 °C/min. Tp is the exothermic peak as 
determined from the DTA spectra and Ø is the heating rate (°C/s). The coefficient of 
determination calculated from linear regression for G-A, G-B and G-C were 0.988, 0.983 
and 0.996, respectively. Data are representative of 3 independent runs. 
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3.3.2 XRD Analysis of GCs 
The principal crystalline phase for the GC-A and GC-C was wollastonite (CaSiO3/ ICDD-
PDF # 10-489), accompanied by hydroxyapatite (Ca5(PO4)3OH/ ICDD-PDF # 9-432) and 
Fluorite (CaF2/ ICDD-PDF # 21-159) as shown in Figure 3-2A,C. The XRD spectrum of 
GC-B, Figure 3-2B, illustrated the same crystalline phases as GC-A and GC-C with an 
extra peak at 2θ = 21.6°, indicating the presence of cristobalite (SiO2/ ICDD-PDF # 39-
1425) as an additional crystalline phase. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2: XRD analysis of GC-A, GC-B and GC-C. 
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Figure 3-3: SEM micrograph of sintered GC-A (A), GC-B (B) and GC-C (C). 
Microstructure of the GCs showed acicular interlocking crystals 
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3.3.3 Microstructure of the GCs 
Fracture surfaces of the GCs showed dense acicular interlocking log crystals, which are 
attributed to wollastonite crystals, Figure 3-3A-C. 
3.3.4 Physical and Mechanical Properties  
The density and Poisson’s ratio for the GCs were 2656-2891 kg/m3 and 0.20-0.21, 
respectively. These values for YZ (the control material) – 6120 kg/m3 and 0.42, 
respectively, (p<0.05) were significantly higher as shown in Table 3-4. The E values for 
the three GCs were 89-100 GPa; though, it was significantly higher for the YZ (212 GPa), 
p<0.05. Furthermore, the Ho values were 4.85-5.17 GPa. These values were not 
significantly different among the three GCs, (p<0.05). YZ had significantly higher Ho 
value of 9.64 GPa, p <0.05. We note that there were significant differences among the 
measurements for the KIC of GC-A, GC-B, GC-C and YZ that exhibited the significantly 
higher value of 10.02 MPa·m0.5, (p<0.05). BI of the GCs ranged between 0.99 and 
1.16 µm-0.5 indicating excellent machinability. This quality was confirmed by the 
quantitative assessment of crack-free and smooth preparation of GCs samples without 
fracturing or chipping. 
3.3.5 Chemical Durability 
The chemical solubility of GC-B samples in 4 % AC, pH=2, were significantly lower 
than those of GC-A and GC-C (p<0.05) as shown in Table 3-4. The wt/A of GC-B 
satisfies the ISO specification (less than 100 µg/cm2), which means that it can be exposed 
to the harsh oral cavity environments and it is comparable to the wt/A value for YZ. The 
significantly lower chemical durability for GC-A and GC-C (higher than 100 µg/cm2 and 
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lower than 2000 µg/cm2) indicated that these GCs could be used as substructure ceramics 
that are veneered with other dental biomaterials and should not be exposed to the oral 
cavity environment. The KIC values of the specimens following chemical durability 
testing in AC for 16 h were not significantly different when compared with the KIC values 
of the original untested specimens (ANOVA p<0.05), Figure 3-4. 
 
Table 3-4: Physical, mechanical and chemical properties of the experimental glass 
ceramics and yttria-stabilized zirconia (YZ). Data are means (SD), n = 3. Different 
superscript letters denote that values are significantly different (p<0.05) based on 
ANOVA and Tukey’s multiple comparisons test. 
Properties GC-A GC-B GC-C YZ 
 
Density  
(ρ, kg/m3) 
2891(6.1) a 2656(20.8) b 2713 (38.5) b 6120(32.5) c 
Poisson’s ratio (ʋ) 0.20(0.020) 0.21(0.070) 0.20(0.009) 0.42(0.100) 
 
Young’s modulus 
(E, GPa) 
89(1.27) a 90(2.98) a 100 (2.09) b 212(4.41) c 
Fracture 
toughness      
(KIC, MPa·m0.5) 
4.62(0.04) a 5.58(0.32) b 4.91(0.26) a 10.02(0.50) c 
 
True hardness 
(Ho, GPa) 
5.17(0.22) a 5.15(0.47) a 4.85(0.12) a 9.64(0.13) b 
 
Brittleness index 
(BI, µm-0.5) 
1.12(0.06) 1.16(0.10) 0.99(0.06) ------- 
Mass loss/Unit 
area (µg/cm2) 
1431(96.80) a 100(12.25) b 987(89.16) c 101(8.84) b 
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Figure 3-4: Fracture toughness values before and after soaking GCs specimens in 
4 %acetic acid (AC) for 16 hours at 80 °C and tris buffered solution (TBS) for 120 days at 
37 °C. Data are mean values (SD), n=3. ANOVA and Tukey’s multiple comparisons test 
were used to analyze the results for each material (p<0.05). There was no significant 
difference between the original fracture toughness values and the values of chemically 
tested specimens in both solutions for GC-A, GC-B and GC-C. 
3.3.6 Degradation Test  
Figure 3-5A illustrates the variation of degradation rates of soaked GCs samples in TBS 
for different time durations starting from 1day up to 120 days. The percentage 
degradation increased incrementally as a function of soaking time. All GCs exhibited no 
weight loss at the first day. Afterward, the degradability values of the GCs increased 
slowly with different percentages. After 120 days, the GC-A had a weight loss of 2.9 % 
and it was significantly higher than that of GC-B and GC-C that were 0.36 % and 0.85 %, 
respectively, (p<0.05), revealing very low solubility of GC-B and GC-C, Figure 3-5B. 
The KIC values of the specimens following chemical degradation testing for 120 days 
GC-A GC-B GC-C 
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were not significantly different (ANOVA p<0.05) when compared with the KIC values of 
the original untested specimens, Figure 3-4. 
 
 
 
 
 
 
 
 
 
 
Figure 3-5: (A) Degradation test of the experimental GCs showing weight loss 
percentage of the GCs specimens after soaking in tris buffered solution from 1 day up to 
120 days. Exponential growth equation was used to show nonlinear fit curve for the 
degradation rates at different timeline. (B) Weight loss percentages of the GC-A, GC-B 
and GC-C at 120 days time point soaking in tris buffered solution. GC-B showed the 
least weight loss percentage. Different letters represent significant statistical difference 
(Simple main effect analysis and Tukey’s multiple comparisons test, p<0.05). Data are 
mean values (SD), n=3. 
GC-A 
GC-B 
GC-C 
GC-B GC-A GC-C 
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3.4 DISCUSSION 
The preparation of the precursor glass plays an important part in the properties of the 
manufactured GCs. In this study the glasses were synthesized by sol-gel chemistry, 
followed by spray drying and calcination, melting and quenching; all these steps improve 
the glass homogeneity and lead to good sintering characteristics of the resultant GCs.24 
The SEM images of the GCs confirmed the formation of dense acicular interlocking 
crystals that ascribed to wollastonite crystals. These blade-like crystals are thought to 
contribute to the strength and toughness of the GCs through blunting and crack seizing 
leading to the prevention of crack-propagation and achieve the high values of the fracture 
toughness.1  
The Young’s modulus of elasticity (E) is of great importance for dental GCs, and it 
represents the stiffness of a material within the elastic range measurement of the stiffness 
biomaterials. A mismatch between the E for bone (4-20 GPa)25,26 and implant 
biomaterials could lead to stress shielding phenomenon.27 The young’s modulus of 
elasticity influences the ability of the implant to transmit stresses to the adjacent bone and 
sustains tissue vitality over time. The lower the Young’s modulus of implant material, the 
better the load distribution to the surrounding tissue with the possible beneficial result of 
new bone formation.28,29 The E value of ~210 GPa for the commercial non-metallic dental 
implant “yttria-stabilized tetragonal zirconia” 6 is similar to that of In-Ceram zirconia. 
These values are 10x higher than that of cortical bone tissue. The E value for the 
experimental wollastonite GCs (89-100 GPa) is half of that for zirconia dental material, 
but it still higher than that of bone tissue. 
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XRD data analysis revealed that all experimental GCs had wollastonite as the principal 
crystals along with different proportions of secondary crystalline phases. However, GC-B 
has cristobalite as additional crystalline phase, which is the stable form of silica (SiO2). 
The formation of cristobalite in GC-B is due to the higher silica within its chemical 
composition. 
One-piece dental implants should be chemically durable to withstand the aggressive oral 
environments e.g. diverse chemical fluids, broad range in pH and periodic high 
magnitude mechanical forces that may accelerate GC degradation by corrosion and 
surface wear.1,30 In this study, the chemical durability of the GCs was tested in 4 % AC 
(pH 2) for 16 h at 80 °C as well as in TBS (pH 7.4) up to 120 days at 37 °C to simulate 
the body conditions whether the material is exposed to the oral environments or 
implanted in bone and soft tissue. The chemical durability of GC-A and GC-C in AC was 
substantially higher than 100 µg/cm2 but less than 2000 µg/cm2. As a result, these GCs 
can be used as core materials but cannot be exposed to oral fluids.21 On the other hand; 
GC-B exhibited the least degradation rate (0.36% weight loss at 120 days soaking in the 
TBS) and the least wt/A (100 µg/cm2) in AC. These results can be related to the 
cristobalite, which is the chemically stable crystalline phase.31 The wt/A of GC-B is 
comparable to that of YZ that is used for dental restoration and is considered to be a 
chemically stable dental material.2 The wt/A and degradation rates of the three GCs were 
dissimilar because of the different initial chemical compositions (Table 3-1), which were 
reflected on the crystallization kinetics of the parent glasses and their mechanical and 
chemical properties. 
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In the current study, we tested the chemical stability of the GC in acidic environment and 
in balanced pH based on ISO 6872 (for dental ceramics) and ISO 10993-14 (Biological 
evaluation of medical devices). However, recent study revealed that basic pH buffer 
environment (pH of 10) resulted in a complete breakdown of the silica network of the 
dental ceramics.32 We plan to evaluate the chemical stability of the synthesized GC in 
basic solution in a future study.  
The mechanical properties of the chemically tested GCs were re-measured to evaluate the 
effect of the degradation and dissolution on their mechanical behavior. E, Ho and KIC 
were assessed, but only the data of the KIC were shown in this study for two reasons. 
First, the equation and the calculation of KIC include both E and Ho and hence any 
changes of these parameters will be reflected on KIC.20 Secondly, the KIC is considered as 
an essential and starting point for the evaluation and selection of the biomaterials for 
clinical applications and it determines the aspects of brittle material mechanical 
behavior.12 Interestingly, there was no significant difference between KIC values for the 
original and chemically-tested specimens indicating that the mechanical behavior of the 
chemically-tested specimens were not affected in spite of the fact of different chemical 
degradation and wt/A of the GC samples. To our knowledge we are the first group who 
evaluated the KIC of the GCs following chemical durability testing. 
Boccaccini23 proposed the brittleness index (BI) as a quantitative evaluation of 
machinability. The BI values of the wollastonite GCs were lower than 4.3 µm-0.5 
indicating excellent machinability. These results were confirmed by cutting, milling and 
preparing GC specimens smoothly without developing cracks, Figure 3-6. Interlocking 
crystals contributed to the machinability of the materials by acting as barriers to suppress 
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crack propagation.33 Machinable GC can be prepared by the CAD-CAM system that 
enables customization of implants for individual patients. Additionally, the upper part of 
the GC can be prepared inside patient’s mouth to function as an abutment part and to 
receive the crown. 
 
 
 
 
 
 
 
 
Figure 3-6: Representative image of machined GC-B specimens. Holes and grooves 
were cut on 1 mm thick disks and bevels with shoulder finish line were prepared on GC 
ingot. The preparation was going smooth without chipping or developing cracks. 
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3.5 CONCLUSIONS  
High strength, chemically durable and machinable sintered GCs were prepared with 
different chemical compositions; the experimental GCs had different crystallization 
kinetics that affects the mechanical and chemical properties of the GCs. The wollastonite 
was the main crystalline phase with other secondary crystalline phases–hydroxyapatite 
(Ca5(PO4)3OH) and Fluorite (CaF2) for the three GCS. Yet, GC-B had an additional 
crystalline phase–cristobalite (SiO2) that could be the main reason for showing an 
excellent chemical durability. Microstructures of GCs revealed acicular interlocking 
crystals that were responsible for the high KIC and to the outstanding machinability. 
Machinable GC-B may be considered as a unique, convenient and propitious biomaterial 
for immediate non-metallic one-piece dental implant applications as alternative to the 
commercial dental implants. 
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CHAPTER 4 
BIOACTIVITY AND BIOCOMPATIBILITY OF A NOVEL 
WOLLASTONITE GLASS-CERAMIC 
This study was performed to further characterize the previously synthesized wollastonite 
GC. In this chapter, the bioactivity and biocompatibility of the wollastonite GC were 
evaluated and they were compared to those of In-Ceram yttria partially stabilized 
zirconia. The contents of this chapter have been submitted for publication. 
4.1 INTRODUCTION  
Zirconia dental implants were introduced as an alternative to titanium dental implants. In 
addition to fulfilling the patients’ demand for a metal-free implant, zirconia dental 
implants overcome some aesthetic problems associated with titanium dental implants.1 
Zirconia implants exhibit unique and favorable physical, mechanical and optical 
properties, while also having excellent resistance to corrosion because of their chemical 
stability and bio-inertness.1-5 Good biocompatibility of zirconia was attributed to 
biointegration, which “is the occurrence of continuity of ceramic implant to bone without 
intervening space at bone/implant interface”,6 similar to the osseointegration obtained 
with titanium dental implants.4,6 Recently, various ceramic implant systems made of 
yttria-stabilized tetragonal zirconia polycrystals (Y-TZP) have become commercially 
available.5,7 However, adequate biological data on zirconia dental implants is not yet 
available due to the lack of long-term clinical studies.7,8 
The clinical usage of zirconia is limited for many reasons. First, machining and/or surface 
modifications of zirconia are difficult.5,9 Second, radioactive elements with long half-lives 
can accompany zirconia. The presence of segregated clusters of radionuclides could harm 
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the surrounding tissues.5,6,10 Third, Y-TZP is susceptible to aging through low-
temperature degradation that compromises long-term clinical performance and increases 
the possibility of subsequent catastrophic implant failure.7,9 
Commercial dental implants (titanium and zirconia) are bioinert and lack bioactivity. 
Biomaterials researchers are interested in improving the bioactivity of implant materials 
through different techniques; the most common method is bioactive coatings that exhibit 
bone-bonding ability.11-13 However, these coatings can de-bond at different locations on 
the implant surface or can undergo non-uniform degradation, which would impair 
osseointegration at the interface between the coated implant and bone.14 Another 
approach to improve bioactivity is to integrate HA as a composite within the implant 
material. As a result, the bioactivity and biocompatibility of the implant material is 
improved,15 but additional investigation is needed to evaluate the effect of the 
incorporated HA on the mechanical properties and clinical in vivo performance of these 
composite materials.9 
Biocompatibility is the ability of a material to provide successful clinical service in a host 
without producing allergic or/and toxic reactions in the surrounding tissues or adverse 
systemic reactions.16 The biocompatibility of zirconia has been evaluated; the bone 
response of zirconia and the inflammation adjacent to zirconia have been shown to be 
satisfactory.2 MCT3T-E1 osteoblastic cells displayed active cellular reactions on zirconia, 
including initial cell attachment, proliferation and differentiation.17,18 Other studies 
demonstrated that Y-TZP showed good attachment and proliferation of osteoblastic cells 
regardless of surface treatment or topography, with no signs of toxic or carcinogenic 
outcomes.19-21 
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Although commercial dental implants, both metallic and ceramic, have good clinical 
performance, both have the limitations of being non-bioactive and non-machinable.1,-2 
Our group has synthesized and characterized a novel WGC for one-piece dental implant 
applications (Saadaldin et al, accepted for publication, DEMA-D-13-00398R1) with the 
appropriate strength, chemical durability and machinability. In the current study, the 
bioactivity and biocompatibility of the WGC were evaluated and compared to In-Ceram 
yttria partially stabilized zirconia (YZ). WGC was found to be bioactive with 
biocompatibility comparable to that of YZ, making WGC a promising material for dental 
implant applications. 
 4.2 MATERIALS AND METHODS 
4.2.1 Materials 
The synthesis of a high strength, chemically durable and machinable WGC in the system 
(SiO2-Al2O3-CaO-CaF2-K2O-B2O3-P2O5-CeO2-Y2O3) and characterization of its 
mechanical and chemical properties were previously reported (Saadaldin et al, accepted 
for publication, DEMA-D-13-00398R1). In-Ceram yttrium partially stabilized zirconia 
(YZ, Zahnfabrik, Berlin, Germany) was used as a control. 
4.2.2 Bioactivity 
In vitro bioactivity of WGC and YZ was evaluated by soaking samples (11 mm x 1 mm) 
in simulated body fluid (SBF) under biomimetic conditions (37 °C, pH 7.24). The 
specimens were soaked for 1, 2 and 4 weeks in SBF that had inorganic ion concentrations 
similar to those of human blood plasma.22 SBF was refreshed every week. At the 
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scheduled time, the specimens were thoroughly rinsed, dried and then evaluated as 
described below. 
4.2.2.1 Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray 
Spectroscopy (EDX) 
The surface layer of the WGC and YZ specimens was imaged before and after soaking in 
SBF using high resolution scanning electron microscopy (LEO 1540XB FIB/SEM Zeiss 
Nano Technology Systems Division, Germany) equipped with an EDX spectrometer. 
Prior to SEM and EDX assessment, all samples were coated with 3 nm osmium metal 
using a Filgen OPC 80T osmium plasma coater. 
4.2.2.2 X-Ray Diffraction (XRD) 
The formation of an apatite surface layer on the soaked specimens was assessed by XRD 
using a rotating anode X-ray diffractometer (Rotaflex RTP 300 RC, Rigaku Corp., Japan) 
operating on Co Kα radiation at 45 kV and 160 mA. Spectra were collected in the 2θ 
range between 2° and 82°, with 0.05° steps and 10°/min scan speed. 2θ for equivalent Cu 
Kα radiation was calculated using Bragg’s Law.23 
4.2.3 Biocompatibility 
4.2.3.1 Osteoblast Attachment and Morphology 
Newborn mouse calvaria-derived MC3T3-E1 Subclone 4 preosteoblastic cells were 
obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). 
MC3T3-E1 cells are similar to primary calvarial osteoblasts in their expression of Runx2, 
bone sialoprotein and osteocalcin, and their ability to form bone-like matrix in vitro and 
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in vivo.24 WGC and YZ discs (11 mm x 1 mm) were cleaned and sterilized using an 
argon-based plasma cleaner PDC-32G (Harrick Plasma, Ithaca, NY, USA), placed in 24-
well plates and then seeded with 5x103 cells/well. MC3T3-E1 cells were cultured in 
serum containing medium, as described elsewhere.25 After 6 and 24 h incubation at 37 °C 
in a humidified atmosphere of 5%CO2 in air, the cells were washed, fixed with 4% 
paraformaldehyde (PFA) in PBS, permeabilized with 0.1% Triton-X 100 in PBS for 
5 min and then blocked using 3% bovine albumin (BSA) for 30 min. For visualization of 
vinculin and filamentous actin (F-actin), substrata were incubated with primary antibody 
against vinculin (1:100 in 3% BSA in PBS; Millipore, Billerica, MA, USA) for 1 h, 
rinsed three times with PBS and then incubated for 1.5 h with Alexa Fluor 488-
conjugated goat anti-mouse IgG secondary antibody (1:200 dilution in 3% BSA in PBS; 
Life Technologies, Burlington, CA) and rhodamine-conjugated phalloidin (1:100 dilution 
in 3% BSA in PBS; Cytoskeleton Inc., Denver, CO, USA). To counterstain nuclei, 
Vectashield (Vector Laboratories, Burlingame CA) with 4', 6-diamidino-2-phenylindole 
dihydrochloride (DAPI) was used.  
An Axio Observer Z.1 fluorescence microscope (Carl Zeiss, Jena, Germany) and 
AxioImager software was used to assess cell attachment, actin distribution and focal 
adhesion formation by capturing images from 10 randomly selected fields from each 
specimen. Cell attachment was analyzed by counting nuclei. The total number of focal 
adhesion per cell was measured by an impartial observer using ImageJ software (National 
Institutes of Health, USA). The average number of focal adhesions (based on vinculin 
labeling) was determined for 10 randomly selected cells on each sample. Three 
independent experiments were performed, each with triplicate specimens. 
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4.2.3.2 Cell Proliferation Assay 
CyQuant® cell proliferation assay kit (Invitrogen, Burlington, CA) was used to assess the 
number of MC3T3-E1 osteoblastic cells on WGC and YZ discs at 1, 3, 5 and 7 days, 
according to the manufacturer’s protocol. 
4.2.3.3 Quantification of Alkaline Phosphatase Activity  
Osteoblast differentiation was evaluated by monitoring alkaline phosphatase (ALP) 
activity. Rat calvarial osteoblasts (passage 2-3) were used for these experiments. Cells 
were generously provided by Dr. D.W. Hamilton (Schulich Dentistry, Western 
University). Cells were isolated from 0-5-day old neonatal Sprague Dawley rats 
according to a previously published protocol.26 Animal procedures were approved by the 
University Council on Animal Care of Western University and were in agreement with 
the Canadian Council on Animal Care. 
ALP was determined by measuring the cleavage of p-nitrophenyl phosphate (SensoLyte® 
pNPP colorimetric assay; ANASPEC, Fremont, CA, USA). Osteoblasts were incubated 
on WGC and YZ discs and cultured for 3 days in standard culture medium.25 Afterwards, 
the medium was replaced by differentiation medium that consisted of standard culture 
medium supplemented with 50 µg/mL ascorbic acid and 2 mM β-glycerophosphate. Cells 
were incubated for an additional 1, 4 and 7 days, refreshing the medium every 2-3 days. 
At the scheduled times, the cell monolayer was washed and then lysed with lysis buffer 
containing 0.2% Triton X-100. The resulting suspension was sedimented at 2500 g for 
10 min at 4°C, and the supernatant was collected and stored at -80 °C. Subsequently, 
50 µL of each sample was mixed with 50 µL of pNPP solution on 96-well clear micro-
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plate by gently shaking the plate for 30 sec, and incubated at 37 °C for 60 min. Reactions 
were terminated by adding 50 µL of 0.05 M NaOH into each well and absorbance was 
read at 405 nm on a micro-plate reader (Tecan Safire, Morrisville, NC, USA). ALP 
activity was calculated according to a series of alkaline phosphatase standards. The 
protein concentration for each sample was calculated using BCATM protein assay kit 
(Thermo Scientific Pierce Biotechnology, Waltham, MA, USA), according to the 
manufacturer’s instructions. ALP activity was normalized to total protein concentration 
and expressed as µg pNP/h/µg total protein.  
4.2.4 Statistical Analyses 
Differences between two groups were evaluated by Student’s t-tests. One-way analysis of 
variance (ANOVA) followed by Tukey’s multiple comparisons test was used to evaluate 
differences among three or more groups. All statistical analyses were accepted as 
significant at p<0.05. Data are expressed as means (SD) of three independent experiments 
(n=3), each with triplicate samples.  
4.3 RESULTS 
4.3.1 Bioactivity: 
4.3.1.1 Scanning Electron Microscopy and Energy Dispersive X-Ray 
Spectroscopy 
WGC and YZ displayed different behaviors when soaked in SBF. SEM revealed the 
surface features of WGC and YZ at 0 weeks before soaking in SBF (Figure 4-1). After 1 
week soaking in SBF, WGC surface morphology changed with the precipitation of a 
partial thin coating. As the soaking time was increased, the formation of a uniform 
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surface layer with morphology similar to that of biomimetic HA27,28 was observed. The 
entire surface of the WGC was fully covered by that layer following 4 weeks of soaking. 
In contrast, no precipitate was observed on the YZ surfaces even after up to 4 weeks of 
soaking in SBF, indicating lack of bioactivity. 
EDX elemental analysis spectra are shown in Figure 4-2. In the case of WGC, Ca and P 
peaks increased in intensity with the gradual reduction of the Si peak after soaking in SBF 
at the different time points. EDX analysis confirmed that the precipitate was Ca-P rich 
and that, at 4 weeks soaking time, Si was no longer detectable. To the contrary, there was 
no change in the EDX spectra of YZ for all the time points up to 4 weeks. The zirconium 
was the principal peak before and after soaking in SBF. Importantly, no phosphorus or 
calcium was detected, in spite of soaking in SBF up to 4 weeks, consistent with the SEM 
data.  
4.3.1.2 X-Ray Diffraction 
XRD patterns of WGC and YZ, before and after soaking in SBF, are shown in Figure 4-3. 
It can be observed that the XRD peaks associated with the starting material gradually 
diminished as soaking time was increased. After 4 weeks, only peaks attributable to 
carbonated HA were observed. The main peaks had 2θ values equal to 26°and 32° 
(Figure 4-3A), confirming the formation of an apatite layer.29 In keeping with the SEM 
and EDX data, XRD did not reveal any carbonated HA on YZ surfaces at any time points 
(Figure 4-3B). Taken together, these findings establish that WGC supports the formation 
of a uniform, thick apatite layer in contrast to YZ, which is not bioactive. 
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Figure 4-1: SEM images of wollastonite glass-ceramic (WGC) and In-Ceram yttria 
partially stabilized zirconia (YZ) before (0 week) and after (1, 2 and 4 weeks) soaking in 
simulated body fluid (SBF). SEM micrographs show the surface features of WGC and YZ 
before soaking in SBF (0 week), and the evolution of HA layer on the WGC surfaces (1, 
2 and 4 weeks). There was no HA formed on YZ surfaces at any time. Scale bar = 3 µm 
in all panels. 
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Figure 4-2: EDX spectra illustrating the elemental analysis of WGC and YZ surfaces 
after 0, 1, 2 and 4 weeks soaking in SBF. EDX spectra of WGC display the peaks of the 
main elements (Si, Ca, P) before and after soaking in SBF. YZ spectra indicate the lack 
of bioactivity by showing the same peak (Zr) at different time points. Spectra are 
representative of three different locations on the specimens’ surfaces. 
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Figure 4-3: XRD pattern of WGC and YZ specimens before and after soaking in SBF. 
(A) XRD spectra of WGC confirmed the gradual formation of poorly crystalline HA 
surface layer. After 4 weeks, WGC is totally covered with HA layer, where XRD showed 
the spectrum of carbonated HA only (PDF # 19-272). The black circles above the spectra 
indicate the main peaks at 26° and 32°. (B) There were no changes in the XRD spectra 
of the YZ at the different time points. 
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4.3.2 Biocompatibility 
4.3.2.1 Osteoblast Attachment and Morphology  
To compare cell attachment and morphology on WGC and YZ surfaces, MC3T3-E1 
osteoblast-like cells were cultured for 6 and 24 h. Fluorescence images indicated that cells 
attached and spread well on both substrata (Figure 4-4). After 6 h, cells had circular 
peripheries and there were no obvious stress fibers on either material (Figure 4-4B, D). 
However, after 24 h, the cells exhibited flattened polygonal morphology with multiple 
cytoplasmic extensions and highly organized actin stress fibers, consistent with extensive 
actin polymerization and adhesion to the substrata (Figure 4-4F,H).  
Regarding cell attachment, there was no significant difference between the number of 
osteoblastic cells on WGC and YZ at either time point (p>0.05, Figure 4-5A). Focal 
adhesions were detected by immunofluorescence imaging of vinculin-labeled cells after 6 
and 24 h of cell incubation (Figure 4-4). The focal adhesion counts on 10 randomly 
selected cells are displayed in Figure 4-5B. The number of the focal adhesion increased 
significantly from 6 to 24 h on WGC (p<0.05); however, there were no significant 
differences in the number of focal adhesions on WGC and YZ at either time. 
4.3.2.2 Cell Proliferation Assay 
The ability of WGC and YZ to support osteoblast proliferation was investigated using the 
CyQuant© cell proliferation assay. Cells were cultured for 1-7 days on both surfaces and 
the number of cells on each material was plotted (Figure 4-6A). Cells proliferated on 
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WGC and YZ and, by day 7, there was significantly higher cells count on both surfaces 
(p<0.05). 
4.3.2.3 Alkaline Phosphatase activity (ALP) 
ALP is a classical marker associated with the early stages of osteoblast differentiation and 
it plays a critical role in promoting mineralization of the extracellular matrix.30,31 
Calvarial cells were cultured on WGC and YZ discs in medium supplemented with 
ascorbic acid and β-glycerophosphate to induce osteoblastic differentiation. ALP activity 
was measured and normalized to the amount of protein per sample (Figure 4-6B). On 
both substrata, ALP activity increased with time. At day 7, the ALP activity was 2.4 fold 
higher than at day 1 for WGC and 1.5 fold for YZ. However, there was no significant 
difference between the ALP activity of cells on WGC and YZ at any time point (p>0.05). 
 
Figure 4-4: Representative fluorescence images of MC3T-E1 cell attachment, 
morphology spreading and focal adhesions on WGC and YZ substrata after 6 and 24 h 
of incubation. Images were captured at low (A, C, E and G) and high (B, D, F and H) 
magnifications. The nuclei were stained with DAPI (blue), F-actin with rhodamine 
phalloidin (red) and focal adhesions with vinculin (green).  
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Figure 4-5: MC3T3-E1 cell count (A) and focal adhesion count (B) on WGC and YZ 
specimens after 6 and 24 h of incubation. There was no significant difference between 
cell count on both materials after 6 or 24 h incubation. On the other hand, focal adhesion 
count increased significantly on WGC after 24 h of incubation. The data are means (SD) 
of 9 samples from 3 independent experiments (n=3). *Indicates significant effect of time, 
analyzed by Student’s t-test (p<0.05).  
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Figure 4-6: (A) MC3T3-E1 cell proliferation on WGC and YZ. CyQuant® fluorescence 
proliferation assay was used to quantify cell number up to 7 days. Data are means (SD), 
n=3. * Indicates that cell number at day 7 was significantly higher than that at day 1, 3, 
and 5 for both materials (p<0.05) based on ANOVA and Tukey’s multiple comparisons 
test. (B) Calvarial osteoblasts were cultured on WGC and YZ specimens for 1, 4 and 
7 days. Alkaline phosphatase activity was measured and normalized to total protein. 
Data are means (SD), n=3. There was no significant difference in ALP activity between 
materials at any time point (ANOVA and Tukey’s multiple comparisons test, p>0.05). 
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4.4 DISCUSSION 
Formation of bone-like apatite is an essential requirement for the bioactivity of materials. 
The first step for predicting in vivo bioactivity of a new material is soaking the material in 
SBF and evaluating the formation of apatite layer on its surface.22 In the present study, 
SEM, EDX and XRD analyses revealed the bioactivity of WGC and confirmed that YZ is 
not bioactive. A bioactive material creates an interface with the surrounding bone and 
promotes a long functional life of the dental implant.32  
Bioactivity mechanisms have been discussed thoroughly in the literature.33-35 It starts with 
apatite nuclei formation on the surface of the biomaterial that later grow over the entire 
surface by consuming calcium and phosphate ions from the SBF. Carbonate anions are 
later incorporated within the formed apatite, leading to formation of carbonated HA.22,33,35 
In the present study, the WGC starting material showed various peaks attributed to the 
crystalline phases of WGC. In spite of the presence of apatite as a secondary crystalline 
phase in WGC (Saadaldin et al, accepted for publication, DEMA-D-13-00398R1), its 
bioactivity was ascribed to an apatite layer that formed on its surface after soaking in 
SBF. After soaking in SBF for increasing times, WGC peaks decreased in intensity until 
they totally disappeared at 4 weeks and were replaced with broad diffraction peaks of 
carbonated HA. These new broadened peaks indicate formation of a poorly crystalline 
structure, similar to bone apatite.36 Kokubo34 developed an apatite-wollastonite GC in an 
MgO-CaO-SiO2-P2O2 glass system. This GC showed bioactivity with satisfactory 
mechanical properties. Kokubo established that, with bioactive materials, osteoblasts 
proliferate on formed apatite surfaces in preference to other cells. Consequently, the 
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surrounding bone comes into direct contact with the GC without intervention of fibrous 
tissue, establishing a strong chemical bond between the formed apatite and the bone 
apatite.34,37 Another study confirmed that bioactive GC could initiate biomineralization in 
osteoblast cultures, leading to a direct bond between the formed apatite layer on the 
bioactive GC and the mineralized extracellular matrix.38 All these studies revealed the 
excellent osteoconductivity of HA layer.  
Cell cultures provide an important tool to determine in vitro biocompatibility of 
biomaterials. Moreover, osteoblast attachment on the implant surface is a key factor for 
successful osseointegration to occur. We focused on the initial cell-implant interactions 
including attachment, focal adhesion formation, proliferation and ALP activity. We 
compared the behavior of WGC to that of a positive control YZ, which exhibits excellent 
biocompatibility, comparable to commercially used titanium dental implants.1,4,7,18,20,39,40 
In the present study, cells exhibited favorable morphological features on WGC and YZ, 
indicating that WGC is comparable in its biocompatibility to YZ.  
The formation of focal adhesions is considered to be one of the early steps essential for 
subsequent cell migration, proliferation and differentiation before formation of bone 
tissue.19 On both WGC and YZ, osteoblasts exhibited focal adhesions indicating that 
extracellular matrix proteins, membrane proteins and cytoskeletal proteins interacted 
together effectively.41 After 24 h, the focal adhesion number on WGC surfaces increased 
significantly compared to the number after 6 h, consistent with a positive enduring 
interaction between the cells and the substratum.42  
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Both WGC and YZ supported cell proliferation. Various osteoblastic cells have been used 
previously to study proliferation kinetics on zirconia and apatite wollastonite composite 
glass ceramic materials. MC3T3-E1 and CAL-72 cell lines proliferated significantly on 
zirconia surfaces.18,41 Similarly, human osteoblasts proliferated and formed dense cell 
layers on zirconia surfaces.19,39 Also, apatite-wollastonite composite glass ceramic 
supported the proliferation of Saos-2 osteoblast-like cells.39  
Osteogenesis through osteoblast differentiation and extracellular matrix formation is 
required for subsequent implant osseointegration. In the current study, primary calvaria 
cells were used to evaluate ALP activity levels on WGC and YZ substrata. Primary cells 
were selected instead of the MC3T3-E1 cell line because most cell lines do not 
demonstrate a complete pattern of in vitro differentiation.21 ALP activity was maintained 
in osteoblasts on both materials at comparable levels. Similarly, previous studies have 
shown that zirconia surfaces, regardless of their roughness or topography, supported ALP 
expression by osteoblastic cells.18,43,44  
Overall, WGC and YZ had comparable interactions with cells. This can be attributed to 
two reasons. First, topography of material plays a critical role in cell-implant 
interaction26,41,45 and both WGC and YZ had relatively smooth surfaces due to the 
sintering process. Second, both of these materials are chemically durable; YZ was proved 
to be bioinert3 and WGC was found to be chemically durable (Saadaldin et al, accepted 
for publication, DEMA-D-13-00398R1). The possible toxicity of WGC and YZ is 
believed to be negligible because of their excellent chemical durability and insignificant 
degradation and dissolution rates. Further in vitro and in vivo studies will be required to 
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understand the effects of WGC on gene expression and to elucidate the interaction 
between oral tissues and the WGC implant material.  
4.5 CONCLUSIONS 
We established that WGC is bioactive and forms a complete apatite layer on its surface 
within 4 weeks in SBF. In vitro biocompatibility tests showed that WGC supported 
osteoblast attachment, focal adhesion formation, cell proliferation and ALP activity. The 
biocompatibility of WGC was comparable to that of the positive control, In-Ceram yttria 
partially stabilized zirconia. We have previously shown that WGC has chemical and 
mechanical properties – including machinability – suitable for the fabrication of one-
piece dental implants (Saadaldin et al, accepted for publication, DEMA-D-13-00398R1), 
The results of the present study establish that WGC is bioactive and biocompatible and, 
thus, a promising material for non-metallic dental implants applications. 
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CHAPTER 5 
GENERAL DISCUSSION 
This chapter provides an overall summary of the important findings, their significance 
and general conclusions of the work. The limitations and future directions are presented. 
Despite substantial gains in the discovery of new materials for dental applications in 
recent years1 there is an ongoing search for dental implant materials to satisfy combined 
properties such as superior mechanical properties, biocompatibility, bioactivity, 
machinability, handling properties and cost. The main goal of this work was to develop 
GCs with suitable mechanical and biological properties for non-metallic one-piece dental 
implant applications. An implant can be the treatment of choice when natural teeth are 
lost and the masticatory function is diminished. Prevalence of partial and complete tooth 
loss is increasing among the population of different ages2 due to many reasons: 
1. Epidemic of dental caries and periodontal disease in modern societies.3  
2. Traumatic dental injuries, as a result of various contributing factors (malocclusion, 
teeth grinding and clenching), physical trauma (motor vehicle accidents, fighting 
and sports injuries), in addition to inappropriate usage of teeth and oral piercing.4  
3. Increased life expectancy and associated increase in older population, especially.5  
4. Congenital missing teeth and other diseases, such as cancer.6  
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Patients have high expectations regarding the esthetics and biocompatibility of their 
dental restorations. Advanced ceramic materials such as zirconia and glass-ceramics (GC) 
have great potential as substitutes for metallic biomaterials. (GCs) have been used to 
fabricate different restorations including veneers, inlays, onlays, crowns and bridges. 
GCs have become one of main interests for dental researchers to improve their esthetic 
outcomes and mechanical properties. GCs properties are determined largely by the 
number of the crystals formed from the base glass, their growth rate and size. To ensure 
superior mechanical performance the GCs, crystals should be numerous and uniformly 
distributed throughout the remaining glassy phase.7  
To the best of our knowledge, we were the first group that synthesized precursor glasses 
by combining wet chemistry and spray drying (Chapters 2 and 3) to synthesize miserite 
and wollastonite GCs. Silicon alkoxides were hydrolyzed in an aqueous solution of 
metallic salts, the resulting sol was spray dried to produce multicomponent powder 
followed by calcination, melting, and quenching to obtain transparent glass frits. Spray 
drying is a well-established technique and a widely used industrial process that uses the 
aerosol phase to produce homogenous,8 highly reactive, and easily sintered glass powder.9 
Sol-gel chemistry improved synthetic methods of the glasses by lowering the melting 
temperatures leading to better material properties.10  
Pinckney et al11 synthesized precursor glasses (to produce miserite GCs) using a 
conventional method: mixing batch components, ball-milling and then melting the 
powder at 1475-1500 °C. This method leads to fluorine loss from the melt; the amount of 
loss is varied and is associated with the difference in melting conditions.12 It was 
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disclosed that the fluorine content in precursor glasses plays a significant role in 
improving the sintering and mechanical properties of GCs.13,14 In the current study, the 
sol-gel chemistry process lead to a lower melting temperature (1250 °C) of the glasses 
(Chapter 2) and kept the intended fluorine content. Differential thermal analysis (DTA) 
data was used to determine the ceramming temperature to produce the GCs. Different 
heat treatment schedules were used to study its effect on the microstructure and 
crystalline phases of the resultant GCs. 
X-ray diffraction (XRD) of the GCs showed multi crystalline phases, including calcium 
fluoride silicate, xonotolite, hydroxyapatite and miserite. The GC that was produced by 
subjecting the glass to heat treatment up to 1000 °C exhibited miserite as the main 
crystalline phase and it was identified as GC4 in the study. GC4 exhibited a 
microstructure of tightly interlocking crystals that contributed to its toughness and 
strength and it is similar to that of miserite GC synthesized in a previous study.11 In spite 
of having the same microstructure and the same main crystalline phase (miserite), their 
fracture toughness (KIC) values were dissimilar. The KIC of GC4 (4.77±0.27 MPa·m0.5) is 
notably higher compared to the KIC values reported by Pinckney et al11 (>3.5 MPa·m0.5). 
The dissimilarity of their KIC can be attributed to the synthesis process of the parent glass 
that affected the mechanical properties of the resultant GCs.  
Young’s modulus (E) is an important mechanical property of implant materials that 
affects its osseointegration and compatibility with adjacent bone.15 In addition, E also 
contributes to the preservation of the vitality of the surrounding bone16 through effective 
transfer of forces to adjacent bone. The E values of the current dental implants such as 
titanium (100-116 GPa)17 and zirconia (200-210 GPa)18 were drastically higher than that 
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of human bone, which can range from 0.61 GPa to17 GPa.17,19,20 GC4 has an E value of 
96±2.54 GPa, that is notably lower than that of  titanium or zirconia, yet a long way from 
an ideal match to that of the human bone. 
GC4 specimens (Chapter 2) exhibited excellent machinability; they were milled and 
machined using conventional drilling tools, indicating the possibility of introducing GC4 
to CAD-CAM systems. The random interlocking microstructure of different GC crystals 
acts as a barrier against catastrophic crack propagation.21 The degree of the interlocking 
of the GC crystals will determine the ease of its machinability.22 Studies showed that 
some machinable materials could suffer from chipping defects, surface flaws, and 
microcracks, which reduce their mechanical strength and lifetime.23 GC4 was milled and 
drilled to prepare different shapes such as marginal finish lines (shoulder, chamfer), 
grooves, holes and bevels without chipping or developing microcracks. The excellent 
machinability of GC4 was assessed quantitatively by calculating the brittleness index 
(BI). Boccaccini 24 proposed BI as a parameter for evaluating the machinability of brittle 
materials like glass and GCs, by combining both KIC and the hardness values to evaluate 
the deformation and micro fracture phenomena responses of the materials.. GC4 had a BI 
value of 1.11±0.05 µm-0.5 indicating excellent machinability. 
Current dental implant materials, titanium and zirconia, have particular properties for 
direct functionability as implant materials, but they lack important features like 
osteogenic and osteoconductive capacity25 or bioactivity.26 Even though different 
mechanical and chemical modifications were applied to improve these qualities, and to 
prevent inflammatory reactions that could lead to fibrous encapsulation of the implant, 
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osteoconductive and bioactivity are still considered critical issues in any implant 
treatment.25  
GC4 specimens exhibited bioactivity; a successful deposition of continuous and compact 
HA layer was detected using XRD, EDX and SEM, after soaking in SBF for 4 weeks. 
The microstructure and chemical composition of the HA layer was similar to the mineral 
phase in bone; this result was in agreement with the outcome of bioactivity testing of 
other biomaterials.27-30 Formation of HA on the implant surfaces leads to direct bonding 
to living tissues without the formation of fibrous tissue that hinders the 
osseointegration.29,31 Alemany et al 29 disclosed the effect of the GC synthesis method 
and the microstructure on bioactivity; GC that was obtained by ceramming a glass that 
prepared by the sol-gel method formed HA layer sooner than that synthesized by the 
conventional method, although both of them exhibited bioactivity.  
Implant biomaterials have to be biocompatible to surrounding cells and tissues, to prevent 
inflammation and osteolysis that occur as a result of toxic or corrosion products, and to 
promote osseointegration and mechanical stability.26 It was shown in the current study 
that osteoblast-like cells attached, spread and proliferated on GC4 in a comparable level 
to biocompatible titanium materials,32-34 indicating its biocompatibility and the absence of 
toxic effects on cells. In spite of the favorable mechanical and biological properties of 
GC4, preliminary results of chemical stability were less promising (Appendix B). As a 
result, we were motivated to modify the composition of the GC to improve the chemical 
durability and to preserve its mechanical and biological properties. 
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In Chapter 3 (Synthesis and characterization of wollastonite glass-ceramics for dental 
implant applications), three precursor glasses were synthesized following the same 
procedure executed in Chapter 2. Glass melting experiments were performed to prepare 
the glasses with the lowest melting temperature to prevent the loss of fluorine and to 
avoid uncontrolled crystallization. DTA was used to determine the crystallization kinetics 
of the GCs.  
XRD of the GC specimens revealed that wollastonite was the main crystalline phase of all 
GCs accompanied with other secondary phases (hydroxyapatite and fluorite). One GC 
had cristobalite as an additional phase and was identified as WGC. Scanning electron 
microscopy (SEM) of the GCs showed dense acicular interlocking crystals. The KIC of 
WGC was significantly higher (p<0.05) than other GCs (4.91±0.26 MPa·m0.5). All GCs 
exhibited excellent machinability. Young’s modulus of WGC was 90±2.98 GPa. In 
summary, WGC had favorable properties with a lower E value and a higher KIC than GC4 
previously synthesized in Chapter 2.  
One of the objectives in Chapter 3 was to test the chemical stability of WGC. The results 
were very encouraging; the WGC weight loss/unit area in 4% acetic acid satisfied ISO 
6872 35 specification for dental ceramics, indicating its superb chemical durability. The 
chemical stability was similar to the chemically durable YZ that is used widely to 
construct dental restorations.36 Degradation testing (ISO 10993-14)37 of the WGC showed 
insignificant degradation ranging from 0% at day 1 to 0.36% after 120 days of soaking in 
tris buffered solution. Assessment of the KIC of WGC after the chemical stability tests 
showed no significant effect on the KIC values (p>0.05), providing support that soaking 
GC specimens in different solutions for various time periods did not affect mechanical 
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properties. In general, we concluded that WGC had both superior chemical stability and 
mechanical properties among the GCs in the study. As a result, it was selected for 
investigation of bioactivity and biocompatibility presented in Chapter 4.  
In chapter 4 (Bioactivity and Biocompatibility of a Novel Wollastonite Glass-Ceramic), 
bioactivity testing of WGC was performed by soaking specimens in SBF for different 
time. SEM, XRD and EDX revealed that WGC promoted the formation of bone-like HA 
on the surfaces of the specimens. These results were in agreement with other in vitro and 
in vivo studies of bioactivity of wollastonite GC.28,30,38-41 The synthesis procedures, 
chemical compositions, and mechanical properties of these GCs were different from the 
WGC that was synthesized in Chapter 3, but all of these GCs including WGC had 
wollastonite as the main crystalline phase. These studies showed that both wollastonite 
and pseudowollastonite GCs were bioactive. It was observed that the formation of apatite 
on wollastonite ceramics was faster than that on other bioglass or GCs in SBF.30 
Bioactivity of dental implants plays a critical role in improving its osseointegration,42 in 
which osteoblast proliferate on the formed apatite layer leading to direct contact between 
implant material and surrounding bone, thus establishing a strong chemical bond between 
the newly formed apatite and bone.28,43  
The biocompatibility of WGC was assessed in Chapter 4 in comparison with the 
biocompatible zirconia (YZ).44-46 All tests compared forwardly to YZ, indicating the 
excellent biocompatibility of WGC and absence of any possible toxic reactions. Attached 
cells showed favorable morphological features of flattened polygonal morphology with 
multiple cytoplasmic extensions accompanied with highly organized actin stress fibers. 
Focal adhesion (FA) formations on WGC increased significantly with increased culture 
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time of the osteoblast cells, indicating a positive reaction of cells. FA is directly related  
to cell spreading under all conditions.47 FA formation is also the indication of subsequent 
cell migration, proliferation, and differentiation that precedes new bone formation.48 
Lastly, WGC supported osteoblast proliferation; a result in agreement with other studies 
of osteoblast proliferation on apatite-wollastonite GC.44,49  
Alkaline phosphatase (ALP) is a widely recognized biochemical marker used to evaluate 
osteoblast differentiation, which is required for osteogenesis and subsequent implant 
osseointegration.50 ALP activity was retained and increased with time on WGC 
specimens, indicating the ability of the osteoblast to differentiate – leading to in vivo 
initiation of bone calcification and consequent HA crystal formation.51 Overall, WGC 
showed positive interactions with osteoblasts by supporting their attachment, 
proliferation, and keeping up FA formation and ALP activity. 
To the best of our knowledge, WGC is a novel material proposed for non-metallic, one-
piece dental implant applications owing to its appropriate mechanical and chemical 
properties, machinability, bioactivity and biocompatibility. WGC is a promising 
biomaterial to satisfy the public as well as the dental profession new trend towards metal-
free restorations. 
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5.1 LIMITATION OF THE RESEARCH AND FUTURE DIRECTIONS 
5.1.1 Limitations  
There are limitations encountered in the work done in the thesis: 
1. In spite of superior mechanical properties, excellent bioactivity and biocompatibility, 
miserite GC exhibited inadequate chemical stability. Modifications of the chemical 
composition and/or heat treatment schedules are required to preserve the miserite as 
the main crystalline phase and to improve its chemical stability – either in accordance 
to ISO 6872 of dental ceramics and in accordance to ISO 10993-14. 
2.  Chemical durability of the GCs was evaluated based on ISO 6872 (on acidic 
environment) and on ISO 10933-14 (in neutral pH). Yet, recent study disclosed that 
basic pH buffer solution (pH of 10) resulted in a complete breakdown of the silica 
network of the dental ceramics.52 
3. Fatigue resistance is an essential property of dental implants. In vitro study disclosed 
that one-piece zirconia and titanium dental implant specimens failed after subjected to 
stepped fatigue-loading test.53 The tests showed that the fatigue strength of zirconia 
was three times lower than that of titanium dental implants. Although Young’s 
modulus, true hardness, and fracture toughness of WGC were considered suitable for 
dental implant applications, another critical property of dental implant such as fatigue 
resistance was not tested.  
4. Mature osteoblasts influence osteoclastogenesis and normal bone remodeling.54 
Hence, further investigation in osteoblast marker gene expressions, mineral deposits 
in the osteoblast cultures and osteoclast activity on WGC specimens will be required.  
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5. The incidences of marginal infection, peri-implant mucositis, and peri-implantitis are 
increasing significantly. These incidences are considered being one of the 
fundamental factors of implant failure.55 Therefore, evaluating the biocompatibility of 
implant materials with gingival fibroblast, bacterial adhesive properties on their 
surfaces, and their anti-inflammatory properties are the fundamental tests for dental 
implants.56 
5.1.2 Future Directions 
This thesis provides the groundwork on the synthesis process, characterization, and 
potential application of a strong, chemically durable, machinable, bioactive, and 
biocompatible wollastonite GC for non-metallic one-piece dental implants. The following 
experiments are suggested to investigate further areas to set the stage for clinical 
applications: 
1. Testing the dynamic fatigue strength of WGC using ISO 14801 standard to 
determine the functional loads of WGC under two different environments – dry and 
simulated body conditions.  
2. Retesting the dynamic fatigue strength of WGC after the assessment of its chemical 
durability in 4% acetic acid for 16 h at 80 °C, and chemical degradation in TBS for 
120 days at 37°C. 
3. Assessment of other bone markers, including osteoblast gene expression markers 
and osteoclast cell activity. 
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4. Conducting in vivo studies in animal models such as dogs or monkeys to investigate 
WGC behavior when implanted in living bone and to ascertain its bioactivity and 
biocompatibility.  
5. Testing the chemical stability of WGC in basic buffered solutions (pH of 10). 
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APPENDIX B 
 
Preliminary results of the Chemical stability of miserite GC (Chapter 2) 
Chemical Durability of miserite GC 
Chemical durability of the miserite GC (GC4) was evaluated by measuring mass loss/ 
unit area after soaking the samples in 4% AC, pH=2, according to ISO standard 6782 for 
dental ceramics. Mass loss was significantly lower than the ISO specification (less than 
100 µg/cm2), which means that GC4 cannot be exposed to the harsh oral cavity 
environments.  
 
Properties GC4 
Mass loss/Unit 
area (µg/cm2) 
8332(490) 
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Chemical Degradation of miserite GC 
Chemical Degradation of GC4 Degradation test of the experimental miserite GC showing 
weight loss percentage of the GC specimens after soaking in tris buffered solution (TBS) 
from 1 day up to 120 days. Weight loss percentage of the specimens was 3% after 120 
days soaking in TBS Exponential growth equation was used to show nonlinear fit curve 
for the degradation rates at different timeline. 
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